Below are the top 10 fastest-growing Small Cap stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. Two Chinese
companies (YOKU, DANG) are on the list. MakeMyTrip Limited (NASDAQ:MMYT) is the
first fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 83.0%. This number is based on the average estimate
of 4 brokerage analysts. Youku Inc (ADR) (NYSE:YOKU) is the second
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 56.9%. This number is based on the average estimate of
3 brokerage analysts. E Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the
third fastest-growing stock in this segment of the market. Its long-term annual
EPS growth is expected to be 53.3%. This number is based on the average estimate
of 3 brokerage analysts. Constant Contact, Inc. (NASDAQ:CTCT) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 40.6%. This number is based on the average estimate of
5 brokerage analysts. Pandora Media Inc (NYSE:P) is the fifth fastest-growing
stock in this segment of the market. Its long-term annual EPS growth is expected
to be 40.0%. This number is based on the average estimate of 3 brokerage
analysts. Qlik Technologies Inc (NASDAQ:QLIK) is the sixth fastest-growing stock
in this segment of the market. Its long-term annual EPS growth is expected to be
39.4%. This number is based on the average estimate of 4 brokerage analysts.
EZchip Semiconductor Ltd. (NASDAQ:EZCH) is the seventh fastest-growing stock in
this segment of the market. Its long-term annual EPS growth is expected to be
39.3%. This number is based on the average estimate of 3 brokerage analysts.
Boyd Gaming Corporation (NYSE:BYD) is the eighth fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 38.5%.
This number is based on the average estimate of 4 brokerage analysts. ZOLL
Medical Corporation (NASDAQ:ZOLL) is the ninth fastest-growing stock in this
segment of the market. Its long-term annual EPS growth is expected to be 37.1%.
This number is based on the average estimate of 7 brokerage analysts. Luminex
Corporation (NASDAQ:LMNX) is the 10th fastest-growing stock in this segment of
the market. Its long-term annual EPS growth is expected to be 37.0%. This number
is based on the average estimate of 5 brokerage analysts.
Thursday, January 5, 2012
Google Alert - antiques coin
| ||
| For what it's worth phillyBurbs.com The small conference room at the Hampton resembled an antiques store as tables were adorned with gold and silver coins, currency, vintage silverware, ... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
Google Alert - antiques coin
| ||
|
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
Top-Performing U.S.-Listed Chinese Stocks (Jan 05, 2012)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the latest top-performing U.S.-listed Chinese stocks. ZHONGPIN INC. (NASDAQ:HOGS) is the best-performing U.S.-listed Chinese stock on Jan. 5. It was up 8.2% on the day. HOGS's upside potential is 67.2% based on brokerage analysts' average target price of $15.92. It is trading at 47.0% of its 52-week high of $20.25, and 44.2% above its 52-week low of $6.60. CNOOC Limited (ADR) (NYSE:CEO) is the second best-performing U.S.-listed Chinese stock on Jan. 5. It was up 6.9% on the day. CEO's upside potential is 13.0% based on brokerage analysts' average target price of $221.93. It is trading at 72.2% of its 52-week high of $271.94, and 39.1% above its 52-week low of $141.27. PetroChina Company Limited (ADR) (NYSE:PTR) is the third best-performing U.S.-listed Chinese stock on Jan. 5. It was up 5.9% on the day. PTR's upside potential is 7.9% based on brokerage analysts' average target price of $150.67. It is trading at 87.9% of its 52-week high of $158.83, and 25.5% above its 52-week low of $111.29. 7 DAYS GROUP HOLDINGS LIMITED(ADR) (NYSE:SVN) is the fourth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 5.7% on the day. SVN's upside potential is 97.6% based on brokerage analysts' average target price of $24.03. It is trading at 50.7% of its 52-week high of $24.00, and 11.8% above its 52-week low of $10.88. China Petroleum & Chemical Corp. (ADR) (NYSE:SNP) is the fifth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 5.1% on the day. SNP's upside potential is 5.8% based on brokerage analysts' average target price of $122.20. It is trading at 99.1% of its 52-week high of $116.54, and 40.0% above its 52-week low of $82.50. Phoenix New Media Ltd ADR (NYSE:FENG) is the sixth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.8% on the day. FENG's upside potential is 82.4% based on brokerage analysts' average target price of $10.67. It is trading at 38.8% of its 52-week high of $15.09, and 39.3% above its 52-week low of $4.20. Youku.com Inc (ADR) (NYSE:YOKU) is the seventh best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.3% on the day. YOKU's upside potential is 76.7% based on brokerage analysts' average target price of $29.14. It is trading at 23.6% of its 52-week high of $69.95, and 19.8% above its 52-week low of $13.76. VanceInfo Technologies Inc.(ADR) (NYSE:VIT) is the eighth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.2% on the day. VIT's upside potential is 68.9% based on brokerage analysts' average target price of $18.24. It is trading at 28.4% of its 52-week high of $37.99, and 74.5% above its 52-week low of $6.19. Perfect World Co., Ltd. (ADR) (NASDAQ:PWRD) is the ninth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.1% on the day. PWRD's upside potential is 100.0% based on brokerage analysts' average target price of $24.00. It is trading at 41.2% of its 52-week high of $29.10, and 33.3% above its 52-week low of $9.00. iSoftStone Holdings Ltd (ADR) (NYSE:ISS) is the 10th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.0% on the day. ISS's upside potential is 86.8% based on brokerage analysts' average target price of $17.20. It is trading at 40.7% of its 52-week high of $22.63, and 62.7% above its 52-week low of $5.66. Qihoo 360 Technology Co Ltd (NYSE:QIHU) is the 11th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 3.8% on the day. QIHU's upside potential is 134.8% based on brokerage analysts' average target price of $34.07. It is trading at 40.1% of its 52-week high of $36.21, and 5.8% above its 52-week low of $13.71. WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the 12th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 3.4% on the day. WX's upside potential is 56.6% based on brokerage analysts' average target price of $18.54. It is trading at 62.0% of its 52-week high of $19.10, and 11.2% above its 52-week low of $10.65. TAL Education Group (ADR) (NYSE:XRS) is the 13th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 2.4% on the day. XRS's upside potential is 50.6% based on brokerage analysts' average target price of $15.43. It is trading at 63.1% of its 52-week high of $16.24, and 21.9% above its 52-week low of $8.41. HiSoft Technology Internatnl Ltd (ADR) (NASDAQ:HSFT) is the 14th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.7% on the day. HSFT's upside potential is 81.8% based on brokerage analysts' average target price of $18.16. It is trading at 29.4% of its 52-week high of $34.00, and 24.6% above its 52-week low of $8.02. Huaneng Power International, Inc. (ADR) (NYSE:HNP) is the 15th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.6% on the day. HNP's upside potential is 7.0% based on brokerage analysts' average target price of $23.32. It is trading at 91.1% of its 52-week high of $23.94, and 41.1% above its 52-week low of $15.45. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is the 16th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.6% on the day. MPEL's upside potential is 54.0% based on brokerage analysts' average target price of $15.37. It is trading at 61.8% of its 52-week high of $16.15, and 54.5% above its 52-week low of $6.46. E Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the 17th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.5% on the day. DANG's upside potential is 86.9% based on brokerage analysts' average target price of $9.83. It is trading at 14.5% of its 52-week high of $36.40, and 28.0% above its 52-week low of $4.11. Mindray Medical International Ltd (ADR) (NYSE:MR) is the 18th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.5% on the day. MR's upside potential is 17.9% based on brokerage analysts' average target price of $31.13. It is trading at 84.6% of its 52-week high of $31.21, and 24.3% above its 52-week low of $21.25. Country Syl Ckng Restaurant Chain Co Ltd (NYSE:CCSC) is the 19th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.4% on the day. CCSC's upside potential is 51.4% based on brokerage analysts' average target price of $12.12. It is trading at 31.8% of its 52-week high of $25.19, and 21.4% above its 52-week low of $6.60. China Mobile Ltd. (ADR) (NYSE:CHL) is the 20th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.2% on the day. CHL's upside potential is 1.5% based on brokerage analysts' average target price of $49.97. It is trading at 94.7% of its 52-week high of $51.98, and 13.1% above its 52-week low of $43.51.
Top Oversold U.S.-Listed Chinese Stocks (Jan 05, 2012)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the latest oversold U.S.-listed Chinese stocks. 51job, Inc. (ADR) (NASDAQ:JOBS) is the most oversold U.S.-listed Chinese stock on Jan. 05. It was down 5.2% on the day. JOBS's upside potential is 64.1% based on brokerage analysts' average target price of $64.50. It is trading at 56.3% of its 52-week high of $69.80, and 7.3% above its 52-week low of $36.62. Jiayuan.com International Ltd (NASDAQ:DATE) is the second most oversold U.S.-listed Chinese stock on Jan. 05. It was down 3.8% on the day. DATE's upside potential is 161.9% based on brokerage analysts' average target price of $15.22. It is trading at 36.0% of its 52-week high of $16.12, and 5.6% above its 52-week low of $5.50. China Lodging Group, Ltd (ADR) (NASDAQ:HTHT) is the third most oversold U.S.-listed Chinese stock on Jan. 05. It was down 3.8% on the day. HTHT's upside potential is 64.3% based on brokerage analysts' average target price of $21.82. It is trading at 54.3% of its 52-week high of $24.47, and 10.7% above its 52-week low of $12.00. Simcere Pharmaceutical Group (ADR) (NYSE:SCR) is the fourth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 3.7% on the day. SCR's upside potential is 9.7% based on brokerage analysts' average target price of $9.98. It is trading at 66.2% of its 52-week high of $13.75, and 27.8% above its 52-week low of $7.12. Focus Media Holding Limited (ADR) (NASDAQ:FMCN) is the fifth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 3.3% on the day. FMCN's upside potential is 104.2% based on brokerage analysts' average target price of $40.23. It is trading at 52.4% of its 52-week high of $37.58, and 124.1% above its 52-week low of $8.79. Spreadtrum Communications, Inc (ADR) (NASDAQ:SPRD) is the sixth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.9% on the day. SPRD's upside potential is 58.8% based on brokerage analysts' average target price of $30.58. It is trading at 64.2% of its 52-week high of $29.98, and 124.2% above its 52-week low of $8.59. Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) is the seventh most oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.4% on the day. CTRP's upside potential is 88.4% based on brokerage analysts' average target price of $44.30. It is trading at 46.5% of its 52-week high of $50.57, and 5.3% above its 52-week low of $22.33. ReneSola Ltd. (ADR) (NYSE:SOL) is the eighth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.4% on the day. SOL's upside potential is 76.6% based on brokerage analysts' average target price of $2.86. It is trading at 12.2% of its 52-week high of $13.25, and 11.7% above its 52-week low of $1.45. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) is the ninth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.2% on the day. YGE's upside potential is 33.8% based on brokerage analysts' average target price of $5.29. It is trading at 29.1% of its 52-week high of $13.59, and 43.6% above its 52-week low of $2.75. AutoNavi Holdings Ltd (ADR) (NASDAQ:AMAP) is the 10th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.7% on the day. AMAP's upside potential is 137.8% based on brokerage analysts' average target price of $22.83. It is trading at 47.5% of its 52-week high of $20.20, and 8.2% above its 52-week low of $8.87. Home Inns & Hotels Management Inc. (ADR) (NASDAQ:HMIN) is the 11th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.4% on the day. HMIN's upside potential is 83.8% based on brokerage analysts' average target price of $47.69. It is trading at 57.8% of its 52-week high of $44.86, and 17.4% above its 52-week low of $22.09. Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) is the 12th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.2% on the day. STP's upside potential is 84.7% based on brokerage analysts' average target price of $4.43. It is trading at 22.2% of its 52-week high of $10.83, and 41.2% above its 52-week low of $1.70. Noah Holdings Limited (ADR) (NYSE:NOAH) is the 13th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.2% on the day. NOAH's upside potential is 232.8% based on brokerage analysts' average target price of $19.96. It is trading at 30.9% of its 52-week high of $19.40, and 4.7% above its 52-week low of $5.73. SINA Corporation (USA) (NASDAQ:SINA) is the 14th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.1% on the day. SINA's upside potential is 98.9% based on brokerage analysts' average target price of $105.37. It is trading at 36.0% of its 52-week high of $147.12, and 13.0% above its 52-week low of $46.86. Shanda Games Limited(ADR) (NASDAQ:GAME) is the 15th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.0% on the day. GAME's upside potential is 61.9% based on brokerage analysts' average target price of $6.65. It is trading at 53.4% of its 52-week high of $7.70, and 18.8% above its 52-week low of $3.46. China Real Estate Information Corp (NASDAQ:CRIC) is the 16th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.9% on the day. CRIC's upside potential is 89.0% based on brokerage analysts' average target price of $8.05. It is trading at 45.9% of its 52-week high of $9.29, and 15.8% above its 52-week low of $3.68. Trina Solar Limited (ADR) (NYSE:TSL) is the 17th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.9% on the day. TSL's upside potential is 86.4% based on brokerage analysts' average target price of $13.07. It is trading at 22.6% of its 52-week high of $31.08, and 32.8% above its 52-week low of $5.28. AsiaInfo-Linkage, Inc. (NASDAQ:ASIA) is the 18th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.8% on the day. ASIA's upside potential is 131.5% based on brokerage analysts' average target price of $17.44. It is trading at 32.9% of its 52-week high of $22.91, and 21.3% above its 52-week low of $6.21. 21Vianet Group Inc (NASDAQ:VNET) is the 19th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.8% on the day. VNET's upside potential is 91.9% based on brokerage analysts' average target price of $17.89. It is trading at 41.7% of its 52-week high of $22.33, and 12.2% above its 52-week low of $8.31. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) is the 20th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.7% on the day. JASO's upside potential is 131.2% based on brokerage analysts' average target price of $3.14. It is trading at 15.9% of its 52-week high of $8.57, and 12.4% above its 52-week low of $1.21.
Gold Price Nearly Hit 200 Day Moving Average ($1,627) a Usual Place to Fall in a Not-Yet-Completed Downward Correction
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Gold Price Close Today : 1619.40 Change : 7.50 or 0.5% Silver Price Close Today : 2926.50 Change : 20.20 cents or 0.7% Gold Silver Ratio Today : 55.336 Change : -0.127 or -0.2% Silver Gold Ratio Today : 0.01807 Change : 0.000041 or 0.2% Platinum Price Close Today : 1412.90 Change : -5.10 or -0.4% Palladium Price Close Today : 638.70 Change : -28.55 or -4.3% S&P 500 : 1,281.06 Change : 3.76 or 0.3% Dow In GOLD$ : $158.49 Change : $ (0.76) or -0.5% Dow in GOLD oz : 7.667 Change : -0.037 or -0.5% Dow in SILVER oz : 424.25 Change : -3.04 or -0.7% Dow Industrial : 12,415.70 Change : -2.72 or 0.0% US Dollar Index : 80.91 Change : 0.782 or 1.0% The GOLD PRICE and the SILVER PRICE both rose today, but with much subdued enthusiasm. Gold closed Comex $7.50 higher at $1,619.40. Silver added 20.2c to 2926.5c. No significant advance here, just hanging on. The GOLD PRICE five day chart has widened out its swings and today posted what might be a double top at $1,625. Now the way of life is that you either advance or fall back, grow or die, unless you are a lichen or a rock under a lichen. If gold cannot pierce $1,625, then ’twill fall back to prove at $1,600 exactly how strong it is. Today GOLD nearly hit its 200 day moving average ($1,627) which would be a usual place to limit an upmove in a not-yet-completed downward correction. Y’all are probably scratching your heads and wondering why in the world a fellow who is so sure silver and gold will be higher this time next year and three to five or more times higher in the next 3 – 10 years would croak so about tomorrow’s outlook? Well, ’cause that’s what the chart shows, and arguing with a chart is like arguing with a road sign: makes you feel good, but doesn’t get you anywhere you want to go. Interpretation is crucial here, because it will tell us whether we see a low lower than $1,524, or whether gold has now put all that trifling behind its back and turned its face to the sun. The SILVER PRICE appears more tired than gold. It has been beating its head against a solid wall of resistance above 2960c, without success. Today silver dropped as low as 2874.5, a little lower than yesterday, which was a little lower than Tuesday. Highs also have been successively lower. And I have just described what? Sounds like a downtrend. To gainsay that outlook silver must beat its way through 2960c and close higher. Patience, patience. I’d rather exercise a little patience here and maybe buy a little higher than buy and watch it sink to a final bottom. Today the US dollar index cashed that check it wrote yesterday. Rose 78.2 basis points (1.01%, giant move) to $80.911, nearly reaching yesterday’s 81.10 target. High struck 81.016. Once the buck worms its way past that 81.00 turnstile, it will run fast for 81.50. What the dollar won, the euro lost. It fell 1.22% to close at 1.2787, face still firmly set on 1.2000 or less. How can I be so sure? Yesterday the euro gapped down, then today gapped down again, closing way below the last low. Down, down, down. Somebody slapped the yen today, knocking it below the lower channel boundary established August thru October. Fell 0.51% to 129.69c/Y100 (Y77.10/$1). Hope of higher yen died today. Stocks were a mess today. Nasdaq and Nasdaq-100 rose slightly, as did the S&P500, but the Dow and other sank, evidencing great confusion and faltering confidence. Today’s Dow chart pictures precisely running out of gas (see chart at www.nasdaq.com) and sputtering to a halt. Dow fell 2.72 (0.02%) to 12,415.70, while the S&P500 rose 0.29% (3.76) to 1,281.06. Today the Dow sank as low as 12,283, crossing the perilous and deadly 12,300 line. Last three days (as well as today’s chart) look like and empty jet fuel tank at 20,000 feet. Dow must breach 12,500 or drop into free fall. Argentum et aurum comparenda sunt — – Gold and silver must be bought. – Franklin Sanders, The Moneychanger The-MoneyChanger.com © 2012, The Moneychanger. May not be republished in any form, including electronically, without our express permission. To avoid confusion, please remember that the comments above have a very short time horizon. Always invest with the primary trend. Gold’s primary trend is up, targeting at least $3,130.00; silver’s primary is up targeting 16:1 gold/silver ratio or $195.66; stocks’ primary trend is down, targeting Dow under 2,900 and worth only one ounce of gold; US$ or US$-denominated assets, primary trend down; real estate bubble has burst, primary trend down. WARNING AND DISCLAIMER. Be advised and warned: Do NOT use these commentaries to trade futures contracts. I don’t intend them for that or write them with that short term trading outlook. I write them for long-term investors in physical metals. Take them as entertainment, but not as a timing service for futures. NOR do I recommend investing in gold or silver Exchange Trade Funds (ETFs). Those are NOT physical metal and I fear one day one or another may go up in smoke. Unless you can breathe smoke, stay away. Call me paranoid, but the surviving rabbit is wary of traps. NOR do I recommend trading futures options or other leveraged paper gold and silver products. These are not for the inexperienced. NOR do I recommend buying gold and silver on margin or with debt. What DO I recommend? Physical gold and silver coins and bars in your own hands. One final warning: NEVER insert a 747 Jumbo Jet up your nose.
#Gold prices benefit from #Eurozone and #Iran crises
XCSFDHG46767FHJHJF
min2664 Gold is again the safe haven of choice for investors after falling almost 19% in the last quarter of 2011. With the deepening debt crisis in Europe and increasing tensions over Iran, almost half of 22 gold traders surveyed by Bloomberg expect gold prices to gain next week. According to Bloomberg, investors are also holding a near-record amount of gold through exchange-traded products after gold prices rose for an 11th consecutive year. With escalating economic and geopolitical risks supporting gold, investors look to be sitting pretty on their bullion hoard, which rose 10% last year against the 1.2% decline in the Standard & Poor’s GSCI Total Return Index of 24 commodities. Exchange-traded products are also shaping up to be the ideal strategy for investors to gain exposure and benefit from the upsurge in gold demand. Learn more about how to invest in gold and other precious metals at Commodities Week Asia 2012 , the leading platform for Asian commodity investors, from speakers such as Peregrine Cust, CIO of Prana Capital; Arno Pilz, Head of Metals Trading of Duet Commodities Fund; Peter Schwendner, Partner of Fortinbras Asset Management; Shayne McGuire, Head of Global Research and Portfolio Manager, GBI Precious Metals Fund of Teachers Retirement System of Texas; and Frank Holmes, CEO and CIO of US Global Investors.
#Gold prices benefit from #Eurozone and #Iran crises
Gold is again the safe haven of choice for investors after falling almost 19%
in the last quarter of 2011. With the deepening debt crisis in Europe and
increasing tensions over Iran, almost half of 22 gold traders surveyed by
Bloomberg expect gold prices to gain next week. According to Bloomberg,
investors are also holding a near-record amount of gold through exchange-traded
products after gold prices rose for an 11th consecutive year. With escalating
economic and geopolitical risks supporting gold, investors look to be sitting
pretty on their bullion hoard, which rose 10% last year against the 1.2% decline
in the Standard & Poors GSCI Total Return Index of 24 commodities.
Exchange-traded products are also shaping up to be the ideal strategy for
investors to gain exposure and benefit from the upsurge in gold demand. Learn
more about how to invest in gold and other precious metals at Commodities Week
Asia 2012 , the leading platform for Asian commodity investors, from speakers
such as Peregrine Cust, CIO of Prana Capital; Arno Pilz, Head of Metals Trading
of Duet Commodities Fund; Peter Schwendner, Partner of Fortinbras Asset
Management; Shayne McGuire, Head of Global Research and Portfolio Manager, GBI
Precious Metals Fund of Teachers Retirement System of Texas; and Frank Holmes,
CEO and CIO of US Global Investors.
in the last quarter of 2011. With the deepening debt crisis in Europe and
increasing tensions over Iran, almost half of 22 gold traders surveyed by
Bloomberg expect gold prices to gain next week. According to Bloomberg,
investors are also holding a near-record amount of gold through exchange-traded
products after gold prices rose for an 11th consecutive year. With escalating
economic and geopolitical risks supporting gold, investors look to be sitting
pretty on their bullion hoard, which rose 10% last year against the 1.2% decline
in the Standard & Poors GSCI Total Return Index of 24 commodities.
Exchange-traded products are also shaping up to be the ideal strategy for
investors to gain exposure and benefit from the upsurge in gold demand. Learn
more about how to invest in gold and other precious metals at Commodities Week
Asia 2012 , the leading platform for Asian commodity investors, from speakers
such as Peregrine Cust, CIO of Prana Capital; Arno Pilz, Head of Metals Trading
of Duet Commodities Fund; Peter Schwendner, Partner of Fortinbras Asset
Management; Shayne McGuire, Head of Global Research and Portfolio Manager, GBI
Precious Metals Fund of Teachers Retirement System of Texas; and Frank Holmes,
CEO and CIO of US Global Investors.
Top 10 Fastest-Growing Large Cap Stocks: LVS, WFT, BIDU, CXO, TLM, EOG, GG, MPC, WYNN, ALXN (Jan 05, 2012)
Below are the top 10 fastest-growing Large Cap stocks, based on the average
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (BIDU) is on the list. Las Vegas Sands Corp. (NYSE:LVS) is the first
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 53.1%. This number is based on the average estimate of
4 brokerage analysts. Weatherford International Ltd. (NYSE:WFT) is the second
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 50.4%. This number is based on the average estimate of
5 brokerage analysts. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the third
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 49.7%. This number is based on the average estimate of
15 brokerage analysts. Concho Resources Inc. (NYSE:CXO) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 49.5%. This number is based on the average estimate of
6 brokerage analysts. Talisman Energy Inc. (USA) (NYSE:TLM) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 45.4%. This number is based on the average estimate of
3 brokerage analysts. EOG Resources, Inc. (NYSE:EOG) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 44.4%. This number is based on the average estimate of
5 brokerage analysts. Goldcorp Inc. (USA) (NYSE:GG) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 43.2%. This number is based on the average estimate of
5 brokerage analysts. Marathon Petroleum Corp (NYSE:MPC) is the eighth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 38.7%. This number is based on the average estimate of
3 brokerage analysts. Wynn Resorts, Limited (NASDAQ:WYNN) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 37.9%. This number is based on the average estimate of
5 brokerage analysts. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is the 10th
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 34.8%. This number is based on the average estimate of
13 brokerage analysts.
long-term earnings growth rate estimated by Wall Street analysts. One Chinese
company (BIDU) is on the list. Las Vegas Sands Corp. (NYSE:LVS) is the first
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 53.1%. This number is based on the average estimate of
4 brokerage analysts. Weatherford International Ltd. (NYSE:WFT) is the second
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 50.4%. This number is based on the average estimate of
5 brokerage analysts. Baidu.com, Inc. (ADR) (NASDAQ:BIDU) is the third
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 49.7%. This number is based on the average estimate of
15 brokerage analysts. Concho Resources Inc. (NYSE:CXO) is the fourth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 49.5%. This number is based on the average estimate of
6 brokerage analysts. Talisman Energy Inc. (USA) (NYSE:TLM) is the fifth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 45.4%. This number is based on the average estimate of
3 brokerage analysts. EOG Resources, Inc. (NYSE:EOG) is the sixth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 44.4%. This number is based on the average estimate of
5 brokerage analysts. Goldcorp Inc. (USA) (NYSE:GG) is the seventh
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 43.2%. This number is based on the average estimate of
5 brokerage analysts. Marathon Petroleum Corp (NYSE:MPC) is the eighth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 38.7%. This number is based on the average estimate of
3 brokerage analysts. Wynn Resorts, Limited (NASDAQ:WYNN) is the ninth
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 37.9%. This number is based on the average estimate of
5 brokerage analysts. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is the 10th
fastest-growing stock in this segment of the market. Its long-term annual EPS
growth is expected to be 34.8%. This number is based on the average estimate of
13 brokerage analysts.
The End of the Big-Box Era
When big-box retail chains like Circuit City, Dillard's (NYSE: DDS ), and
Office Depot (NYSE: ODP ) started to close doors in 2008 and 2009, it made
sense. The recession crimped consumer spending, and these oversized,
over-staffed, and over-inventoried stores had to shed some dead weight in order
to survive. A funny thing happened on the road to recovery in 2010 and 2011,
though: These big-box retailers didn't pull out of their nosedive. More
casualties are on the way, and unfortunately not to mention needlessly, in many
cases these retailers are powerless to prevent their own demise. What separates
the survivors from the also-rans? It's not an easy answer, but there is an
answer. Investors, take note, because the men are about to be separated from the
boys in a contest that really should have happened a long time ago. More Than a
Few, and More than a Fad Make no mistake about it big box retailers are a dying
breed. Were it just one or two struggling to stay above water, we could probably
just chalk it up to poor decision-making or off-target marketing. When a bunch
of them are in dire straits, though, it's not weak management; it's an
epidemic without a super-clear cure. Best Buy (NYSE: BBY ) recently decided to
close down its 11 United Kingdom stores, each of which qualifies as a big-box
unit, after closing its namesake stores in China in early 2011. Sears Holdings
(NASDAQ: SHLD ) announced a few days ago that it will be shuttering around 100
stores. In October, Lowe's (NYSE: LOW ) revealed plans to close 20 stores and
reel in plans to open new ones. And the list goes on: Border's, Linens 'n
Things, and more. These aren't just closings for the sake of appearing to care
about every penny making (or not making) it to the bottom line, either. These
outfits are in real trouble. Sales at Sears stores open at least 12 months, for
example, have fallen every year since the new company (which includes Kmart) was
recreated in 2005. Sears and Best Buy are facing similar struggles. Even the
venerable Wal-Mart Stores (NYSE: WMT ) is struggling. Sure, Wal-Mart hasnt been
closing stores left and right, and it has actually been growing its top line.
But only international growth is improving. In the middle of the year, the
world's biggest retailer posted its eighth straight quarterly decline in
domestic same-store sales. We've seen hints that the domestic revenue
downtrend has slowed in the meantime, but it's a tepid and questionable trend
turnaround. In a similarly startling statistic, data from CoStar Group shows
that the square footage of new shopping centers developed in 2010 reached a
40-year low. Only 12 million square feet of shopping-center space versus an
average of 132 million was finished in 2010. No final tally on 2011's builds,
but considering that mall-vacancy rates ended the third quarter of 2011 at a
record 9.4%, it's hard to imagine why last year's total build-out would be
any better. Whats Going On? Of course, the million-dollar question particularly
if you're one of the retailers with your head on the chopping block is
"what's causing this phenomenon?" If you can answer that, you might have a
shot at surviving, right? Well, no, not really…at least not in this case. The
smartphone (and by extension, the Web) is getting the bulk of the blame for the
demise of
Office Depot (NYSE: ODP ) started to close doors in 2008 and 2009, it made
sense. The recession crimped consumer spending, and these oversized,
over-staffed, and over-inventoried stores had to shed some dead weight in order
to survive. A funny thing happened on the road to recovery in 2010 and 2011,
though: These big-box retailers didn't pull out of their nosedive. More
casualties are on the way, and unfortunately not to mention needlessly, in many
cases these retailers are powerless to prevent their own demise. What separates
the survivors from the also-rans? It's not an easy answer, but there is an
answer. Investors, take note, because the men are about to be separated from the
boys in a contest that really should have happened a long time ago. More Than a
Few, and More than a Fad Make no mistake about it big box retailers are a dying
breed. Were it just one or two struggling to stay above water, we could probably
just chalk it up to poor decision-making or off-target marketing. When a bunch
of them are in dire straits, though, it's not weak management; it's an
epidemic without a super-clear cure. Best Buy (NYSE: BBY ) recently decided to
close down its 11 United Kingdom stores, each of which qualifies as a big-box
unit, after closing its namesake stores in China in early 2011. Sears Holdings
(NASDAQ: SHLD ) announced a few days ago that it will be shuttering around 100
stores. In October, Lowe's (NYSE: LOW ) revealed plans to close 20 stores and
reel in plans to open new ones. And the list goes on: Border's, Linens 'n
Things, and more. These aren't just closings for the sake of appearing to care
about every penny making (or not making) it to the bottom line, either. These
outfits are in real trouble. Sales at Sears stores open at least 12 months, for
example, have fallen every year since the new company (which includes Kmart) was
recreated in 2005. Sears and Best Buy are facing similar struggles. Even the
venerable Wal-Mart Stores (NYSE: WMT ) is struggling. Sure, Wal-Mart hasnt been
closing stores left and right, and it has actually been growing its top line.
But only international growth is improving. In the middle of the year, the
world's biggest retailer posted its eighth straight quarterly decline in
domestic same-store sales. We've seen hints that the domestic revenue
downtrend has slowed in the meantime, but it's a tepid and questionable trend
turnaround. In a similarly startling statistic, data from CoStar Group shows
that the square footage of new shopping centers developed in 2010 reached a
40-year low. Only 12 million square feet of shopping-center space versus an
average of 132 million was finished in 2010. No final tally on 2011's builds,
but considering that mall-vacancy rates ended the third quarter of 2011 at a
record 9.4%, it's hard to imagine why last year's total build-out would be
any better. Whats Going On? Of course, the million-dollar question particularly
if you're one of the retailers with your head on the chopping block is
"what's causing this phenomenon?" If you can answer that, you might have a
shot at surviving, right? Well, no, not really…at least not in this case. The
smartphone (and by extension, the Web) is getting the bulk of the blame for the
demise of
Gold Price Nearly Hit 200 Day Moving Average ($1,627) a Usual Place to Fall in a Not-Yet-Completed Downward Correction
Gold Price Close Today : 1619.40 Change : 7.50 or 0.5% Silver Price Close Today
: 2926.50 Change : 20.20 cents or 0.7% Gold Silver Ratio Today : 55.336 Change :
-0.127 or -0.2% Silver Gold Ratio Today : 0.01807 Change : 0.000041 or 0.2%
Platinum Price Close Today : 1412.90 Change : -5.10 or -0.4% Palladium Price
Close Today : 638.70 Change : -28.55 or -4.3% S&P 500 : 1,281.06 Change : 3.76
or 0.3% Dow In GOLD$ : $158.49 Change : $ (0.76) or -0.5% Dow in GOLD oz : 7.667
Change : -0.037 or -0.5% Dow in SILVER oz : 424.25 Change : -3.04 or -0.7% Dow
Industrial : 12,415.70 Change : -2.72 or 0.0% US Dollar Index : 80.91 Change :
0.782 or 1.0% The GOLD PRICE and the SILVER PRICE both rose today, but with much
subdued enthusiasm. Gold closed Comex $7.50 higher at $1,619.40. Silver added
20.2c to 2926.5c. No significant advance here, just hanging on. The GOLD PRICE
five day chart has widened out its swings and today posted what might be a
double top at $1,625. Now the way of life is that you either advance or fall
back, grow or die, unless you are a lichen or a rock under a lichen. If gold
cannot pierce $1,625, then 'twill fall back to prove at $1,600 exactly how
strong it is. Today GOLD nearly hit its 200 day moving average ($1,627) which
would be a usual place to limit an upmove in a not-yet-completed downward
correction. Y'all are probably scratching your heads and wondering why in the
world a fellow who is so sure silver and gold will be higher this time next year
and three to five or more times higher in the next 3 - 10 years would croak so
about tomorrow's outlook? Well, 'cause that's what the chart shows, and arguing
with a chart is like arguing with a road sign: makes you feel good, but doesn't
get you anywhere you want to go. Interpretation is crucial here, because it will
tell us whether we see a low lower than $1,524, or whether gold has now put all
that trifling behind its back and turned its face to the sun. The SILVER PRICE
appears more tired than gold. It has been beating its head against a solid wall
of resistance above 2960c, without success. Today silver dropped as low as
2874.5, a little lower than yesterday, which was a little lower than Tuesday.
Highs also have been successively lower. And I have just described what? Sounds
like a downtrend. To gainsay that outlook silver must beat its way through 2960c
and close higher. Patience, patience. I'd rather exercise a little patience here
and maybe buy a little higher than buy and watch it sink to a final bottom.
Today the US dollar index cashed that check it wrote yesterday. Rose 78.2 basis
points (1.01%, giant move) to $80.911, nearly reaching yesterday's 81.10 target.
High struck 81.016. Once the buck worms its way past that 81.00 turnstile, it
will run fast for 81.50. What the dollar won, the euro lost. It fell 1.22% to
close at 1.2787, face still firmly set on 1.2000 or less. How can I be so sure?
Yesterday the euro gapped down, then today gapped down again, closing way below
the last low. Down, down, down. Somebody slapped the yen today, knocking it
below the lower channel boundary established August thru October. Fell 0.51% to
129.69c/Y100 (Y77.10/$1). Hope of higher yen died today. Stocks were a mess
today. Nasdaq and Nasdaq-100 rose slightly, as did the S&P500, but the Dow and
other sank, evidencing great confusion and faltering confidence. Today's Dow
chart pictures precisely running out of gas (see chart at www.nasdaq.com) and
sputtering to a halt. Dow fell 2.72 (0.02%) to 12,415.70, while the S&P500 rose
0.29% (3.76) to 1,281.06. Today the Dow sank as low as 12,283, crossing the
perilous and deadly 12,300 line. Last three days (as well as today's chart) look
like and empty jet fuel tank at 20,000 feet. Dow must breach 12,500 or drop into
free fall. Argentum et aurum comparenda sunt -- -- Gold and silver must be
bought. - Franklin Sanders, The Moneychanger The-MoneyChanger.com © 2012, The
Moneychanger. May not be republished in any form, including electronically,
without our express permission. To avoid confusion, please remember that the
comments above have a very short time horizon. Always invest with the primary
trend. Gold's primary trend is up, targeting at least $3,130.00; silver's
primary is up targeting 16:1 gold/silver ratio or $195.66; stocks' primary trend
is down, targeting Dow under 2,900 and worth only one ounce of gold; US$ or
US$-denominated assets, primary trend down; real estate bubble has burst,
primary trend down. WARNING AND DISCLAIMER. Be advised and warned: Do NOT use
these commentaries to trade futures contracts. I don't intend them for that or
write them with that short term trading outlook. I write them for long-term
investors in physical metals. Take them as entertainment, but not as a timing
service for futures. NOR do I recommend investing in gold or silver Exchange
Trade Funds (ETFs). Those are NOT physical metal and I fear one day one or
another may go up in smoke. Unless you can breathe smoke, stay away. Call me
paranoid, but the surviving rabbit is wary of traps. NOR do I recommend trading
futures options or other leveraged paper gold and silver products. These are not
for the inexperienced. NOR do I recommend buying gold and silver on margin or
with debt. What DO I recommend? Physical gold and silver coins and bars in your
own hands. One final warning: NEVER insert a 747 Jumbo Jet up your nose.
: 2926.50 Change : 20.20 cents or 0.7% Gold Silver Ratio Today : 55.336 Change :
-0.127 or -0.2% Silver Gold Ratio Today : 0.01807 Change : 0.000041 or 0.2%
Platinum Price Close Today : 1412.90 Change : -5.10 or -0.4% Palladium Price
Close Today : 638.70 Change : -28.55 or -4.3% S&P 500 : 1,281.06 Change : 3.76
or 0.3% Dow In GOLD$ : $158.49 Change : $ (0.76) or -0.5% Dow in GOLD oz : 7.667
Change : -0.037 or -0.5% Dow in SILVER oz : 424.25 Change : -3.04 or -0.7% Dow
Industrial : 12,415.70 Change : -2.72 or 0.0% US Dollar Index : 80.91 Change :
0.782 or 1.0% The GOLD PRICE and the SILVER PRICE both rose today, but with much
subdued enthusiasm. Gold closed Comex $7.50 higher at $1,619.40. Silver added
20.2c to 2926.5c. No significant advance here, just hanging on. The GOLD PRICE
five day chart has widened out its swings and today posted what might be a
double top at $1,625. Now the way of life is that you either advance or fall
back, grow or die, unless you are a lichen or a rock under a lichen. If gold
cannot pierce $1,625, then 'twill fall back to prove at $1,600 exactly how
strong it is. Today GOLD nearly hit its 200 day moving average ($1,627) which
would be a usual place to limit an upmove in a not-yet-completed downward
correction. Y'all are probably scratching your heads and wondering why in the
world a fellow who is so sure silver and gold will be higher this time next year
and three to five or more times higher in the next 3 - 10 years would croak so
about tomorrow's outlook? Well, 'cause that's what the chart shows, and arguing
with a chart is like arguing with a road sign: makes you feel good, but doesn't
get you anywhere you want to go. Interpretation is crucial here, because it will
tell us whether we see a low lower than $1,524, or whether gold has now put all
that trifling behind its back and turned its face to the sun. The SILVER PRICE
appears more tired than gold. It has been beating its head against a solid wall
of resistance above 2960c, without success. Today silver dropped as low as
2874.5, a little lower than yesterday, which was a little lower than Tuesday.
Highs also have been successively lower. And I have just described what? Sounds
like a downtrend. To gainsay that outlook silver must beat its way through 2960c
and close higher. Patience, patience. I'd rather exercise a little patience here
and maybe buy a little higher than buy and watch it sink to a final bottom.
Today the US dollar index cashed that check it wrote yesterday. Rose 78.2 basis
points (1.01%, giant move) to $80.911, nearly reaching yesterday's 81.10 target.
High struck 81.016. Once the buck worms its way past that 81.00 turnstile, it
will run fast for 81.50. What the dollar won, the euro lost. It fell 1.22% to
close at 1.2787, face still firmly set on 1.2000 or less. How can I be so sure?
Yesterday the euro gapped down, then today gapped down again, closing way below
the last low. Down, down, down. Somebody slapped the yen today, knocking it
below the lower channel boundary established August thru October. Fell 0.51% to
129.69c/Y100 (Y77.10/$1). Hope of higher yen died today. Stocks were a mess
today. Nasdaq and Nasdaq-100 rose slightly, as did the S&P500, but the Dow and
other sank, evidencing great confusion and faltering confidence. Today's Dow
chart pictures precisely running out of gas (see chart at www.nasdaq.com) and
sputtering to a halt. Dow fell 2.72 (0.02%) to 12,415.70, while the S&P500 rose
0.29% (3.76) to 1,281.06. Today the Dow sank as low as 12,283, crossing the
perilous and deadly 12,300 line. Last three days (as well as today's chart) look
like and empty jet fuel tank at 20,000 feet. Dow must breach 12,500 or drop into
free fall. Argentum et aurum comparenda sunt -- -- Gold and silver must be
bought. - Franklin Sanders, The Moneychanger The-MoneyChanger.com © 2012, The
Moneychanger. May not be republished in any form, including electronically,
without our express permission. To avoid confusion, please remember that the
comments above have a very short time horizon. Always invest with the primary
trend. Gold's primary trend is up, targeting at least $3,130.00; silver's
primary is up targeting 16:1 gold/silver ratio or $195.66; stocks' primary trend
is down, targeting Dow under 2,900 and worth only one ounce of gold; US$ or
US$-denominated assets, primary trend down; real estate bubble has burst,
primary trend down. WARNING AND DISCLAIMER. Be advised and warned: Do NOT use
these commentaries to trade futures contracts. I don't intend them for that or
write them with that short term trading outlook. I write them for long-term
investors in physical metals. Take them as entertainment, but not as a timing
service for futures. NOR do I recommend investing in gold or silver Exchange
Trade Funds (ETFs). Those are NOT physical metal and I fear one day one or
another may go up in smoke. Unless you can breathe smoke, stay away. Call me
paranoid, but the surviving rabbit is wary of traps. NOR do I recommend trading
futures options or other leveraged paper gold and silver products. These are not
for the inexperienced. NOR do I recommend buying gold and silver on margin or
with debt. What DO I recommend? Physical gold and silver coins and bars in your
own hands. One final warning: NEVER insert a 747 Jumbo Jet up your nose.
Top-Performing U.S.-Listed Chinese Stocks (Jan 05, 2012)
Below are the latest top-performing U.S.-listed Chinese stocks. ZHONGPIN INC.
(NASDAQ:HOGS) is the best-performing U.S.-listed Chinese stock on Jan. 5. It was
up 8.2% on the day. HOGSs upside potential is 67.2% based on brokerage analysts
average target price of $15.92. It is trading at 47.0% of its 52-week high of
$20.25, and 44.2% above its 52-week low of $6.60. CNOOC Limited (ADR) (NYSE:CEO)
is the second best-performing U.S.-listed Chinese stock on Jan. 5. It was up
6.9% on the day. CEOs upside potential is 13.0% based on brokerage analysts
average target price of $221.93. It is trading at 72.2% of its 52-week high of
$271.94, and 39.1% above its 52-week low of $141.27. PetroChina Company Limited
(ADR) (NYSE:PTR) is the third best-performing U.S.-listed Chinese stock on Jan.
5. It was up 5.9% on the day. PTRs upside potential is 7.9% based on brokerage
analysts average target price of $150.67. It is trading at 87.9% of its 52-week
high of $158.83, and 25.5% above its 52-week low of $111.29. 7 DAYS GROUP
HOLDINGS LIMITED(ADR) (NYSE:SVN) is the fourth best-performing U.S.-listed
Chinese stock on Jan. 5. It was up 5.7% on the day. SVNs upside potential is
97.6% based on brokerage analysts average target price of $24.03. It is trading
at 50.7% of its 52-week high of $24.00, and 11.8% above its 52-week low of
$10.88. China Petroleum & Chemical Corp. (ADR) (NYSE:SNP) is the fifth
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 5.1% on the day.
SNPs upside potential is 5.8% based on brokerage analysts average target price
of $122.20. It is trading at 99.1% of its 52-week high of $116.54, and 40.0%
above its 52-week low of $82.50. Phoenix New Media Ltd ADR (NYSE:FENG) is the
sixth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.8% on the
day. FENGs upside potential is 82.4% based on brokerage analysts average target
price of $10.67. It is trading at 38.8% of its 52-week high of $15.09, and 39.3%
above its 52-week low of $4.20. Youku.com Inc (ADR) (NYSE:YOKU) is the seventh
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.3% on the day.
YOKUs upside potential is 76.7% based on brokerage analysts average target price
of $29.14. It is trading at 23.6% of its 52-week high of $69.95, and 19.8% above
its 52-week low of $13.76. VanceInfo Technologies Inc.(ADR) (NYSE:VIT) is the
eighth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.2% on
the day. VITs upside potential is 68.9% based on brokerage analysts average
target price of $18.24. It is trading at 28.4% of its 52-week high of $37.99,
and 74.5% above its 52-week low of $6.19. Perfect World Co., Ltd. (ADR)
(NASDAQ:PWRD) is the ninth best-performing U.S.-listed Chinese stock on Jan. 5.
It was up 4.1% on the day. PWRDs upside potential is 100.0% based on brokerage
analysts average target price of $24.00. It is trading at 41.2% of its 52-week
high of $29.10, and 33.3% above its 52-week low of $9.00. iSoftStone Holdings
Ltd (ADR) (NYSE:ISS) is the 10th best-performing U.S.-listed Chinese stock on
Jan. 5. It was up 4.0% on the day. ISSs upside potential is 86.8% based on
brokerage analysts average target price of $17.20. It is trading at 40.7% of its
52-week high of $22.63, and 62.7% above its 52-week low of $5.66. Qihoo 360
Technology Co Ltd (NYSE:QIHU) is the 11th best-performing U.S.-listed Chinese
stock on Jan. 5. It was up 3.8% on the day. QIHUs upside potential is 134.8%
based on brokerage analysts average target price of $34.07. It is trading at
40.1% of its 52-week high of $36.21, and 5.8% above its 52-week low of $13.71.
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the 12th best-performing
U.S.-listed Chinese stock on Jan. 5. It was up 3.4% on the day. WXs upside
potential is 56.6% based on brokerage analysts average target price of $18.54.
It is trading at 62.0% of its 52-week high of $19.10, and 11.2% above its
52-week low of $10.65. TAL Education Group (ADR) (NYSE:XRS) is the 13th
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 2.4% on the day.
XRSs upside potential is 50.6% based on brokerage analysts average target price
of $15.43. It is trading at 63.1% of its 52-week high of $16.24, and 21.9% above
its 52-week low of $8.41. HiSoft Technology Internatnl Ltd (ADR) (NASDAQ:HSFT)
is the 14th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.7%
on the day. HSFTs upside potential is 81.8% based on brokerage analysts average
target price of $18.16. It is trading at 29.4% of its 52-week high of $34.00,
and 24.6% above its 52-week low of $8.02. Huaneng Power International, Inc.
(ADR) (NYSE:HNP) is the 15th best-performing U.S.-listed Chinese stock on Jan.
5. It was up 1.6% on the day. HNPs upside potential is 7.0% based on brokerage
analysts average target price of $23.32. It is trading at 91.1% of its 52-week
high of $23.94, and 41.1% above its 52-week low of $15.45. Melco Crown
Entertainment Ltd (ADR) (NASDAQ:MPEL) is the 16th best-performing U.S.-listed
Chinese stock on Jan. 5. It was up 1.6% on the day. MPELs upside potential is
54.0% based on brokerage analysts average target price of $15.37. It is trading
at 61.8% of its 52-week high of $16.15, and 54.5% above its 52-week low of
$6.46. E Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the 17th
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.5% on the day.
DANGs upside potential is 86.9% based on brokerage analysts average target price
of $9.83. It is trading at 14.5% of its 52-week high of $36.40, and 28.0% above
its 52-week low of $4.11. Mindray Medical International Ltd (ADR) (NYSE:MR) is
the 18th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.5% on
the day. MRs upside potential is 17.9% based on brokerage analysts average
target price of $31.13. It is trading at 84.6% of its 52-week high of $31.21,
and 24.3% above its 52-week low of $21.25. Country Syl Ckng Restaurant Chain Co
Ltd (NYSE:CCSC) is the 19th best-performing U.S.-listed Chinese stock on Jan. 5.
It was up 1.4% on the day. CCSCs upside potential is 51.4% based on brokerage
analysts average target price of $12.12. It is trading at 31.8% of its 52-week
high of $25.19, and 21.4% above its 52-week low of $6.60. China Mobile Ltd.
(ADR) (NYSE:CHL) is the 20th best-performing U.S.-listed Chinese stock on Jan.
5. It was up 1.2% on the day. CHLs upside potential is 1.5% based on brokerage
analysts average target price of $49.97. It is trading at 94.7% of its 52-week
high of $51.98, and 13.1% above its 52-week low of $43.51.
(NASDAQ:HOGS) is the best-performing U.S.-listed Chinese stock on Jan. 5. It was
up 8.2% on the day. HOGSs upside potential is 67.2% based on brokerage analysts
average target price of $15.92. It is trading at 47.0% of its 52-week high of
$20.25, and 44.2% above its 52-week low of $6.60. CNOOC Limited (ADR) (NYSE:CEO)
is the second best-performing U.S.-listed Chinese stock on Jan. 5. It was up
6.9% on the day. CEOs upside potential is 13.0% based on brokerage analysts
average target price of $221.93. It is trading at 72.2% of its 52-week high of
$271.94, and 39.1% above its 52-week low of $141.27. PetroChina Company Limited
(ADR) (NYSE:PTR) is the third best-performing U.S.-listed Chinese stock on Jan.
5. It was up 5.9% on the day. PTRs upside potential is 7.9% based on brokerage
analysts average target price of $150.67. It is trading at 87.9% of its 52-week
high of $158.83, and 25.5% above its 52-week low of $111.29. 7 DAYS GROUP
HOLDINGS LIMITED(ADR) (NYSE:SVN) is the fourth best-performing U.S.-listed
Chinese stock on Jan. 5. It was up 5.7% on the day. SVNs upside potential is
97.6% based on brokerage analysts average target price of $24.03. It is trading
at 50.7% of its 52-week high of $24.00, and 11.8% above its 52-week low of
$10.88. China Petroleum & Chemical Corp. (ADR) (NYSE:SNP) is the fifth
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 5.1% on the day.
SNPs upside potential is 5.8% based on brokerage analysts average target price
of $122.20. It is trading at 99.1% of its 52-week high of $116.54, and 40.0%
above its 52-week low of $82.50. Phoenix New Media Ltd ADR (NYSE:FENG) is the
sixth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.8% on the
day. FENGs upside potential is 82.4% based on brokerage analysts average target
price of $10.67. It is trading at 38.8% of its 52-week high of $15.09, and 39.3%
above its 52-week low of $4.20. Youku.com Inc (ADR) (NYSE:YOKU) is the seventh
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.3% on the day.
YOKUs upside potential is 76.7% based on brokerage analysts average target price
of $29.14. It is trading at 23.6% of its 52-week high of $69.95, and 19.8% above
its 52-week low of $13.76. VanceInfo Technologies Inc.(ADR) (NYSE:VIT) is the
eighth best-performing U.S.-listed Chinese stock on Jan. 5. It was up 4.2% on
the day. VITs upside potential is 68.9% based on brokerage analysts average
target price of $18.24. It is trading at 28.4% of its 52-week high of $37.99,
and 74.5% above its 52-week low of $6.19. Perfect World Co., Ltd. (ADR)
(NASDAQ:PWRD) is the ninth best-performing U.S.-listed Chinese stock on Jan. 5.
It was up 4.1% on the day. PWRDs upside potential is 100.0% based on brokerage
analysts average target price of $24.00. It is trading at 41.2% of its 52-week
high of $29.10, and 33.3% above its 52-week low of $9.00. iSoftStone Holdings
Ltd (ADR) (NYSE:ISS) is the 10th best-performing U.S.-listed Chinese stock on
Jan. 5. It was up 4.0% on the day. ISSs upside potential is 86.8% based on
brokerage analysts average target price of $17.20. It is trading at 40.7% of its
52-week high of $22.63, and 62.7% above its 52-week low of $5.66. Qihoo 360
Technology Co Ltd (NYSE:QIHU) is the 11th best-performing U.S.-listed Chinese
stock on Jan. 5. It was up 3.8% on the day. QIHUs upside potential is 134.8%
based on brokerage analysts average target price of $34.07. It is trading at
40.1% of its 52-week high of $36.21, and 5.8% above its 52-week low of $13.71.
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the 12th best-performing
U.S.-listed Chinese stock on Jan. 5. It was up 3.4% on the day. WXs upside
potential is 56.6% based on brokerage analysts average target price of $18.54.
It is trading at 62.0% of its 52-week high of $19.10, and 11.2% above its
52-week low of $10.65. TAL Education Group (ADR) (NYSE:XRS) is the 13th
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 2.4% on the day.
XRSs upside potential is 50.6% based on brokerage analysts average target price
of $15.43. It is trading at 63.1% of its 52-week high of $16.24, and 21.9% above
its 52-week low of $8.41. HiSoft Technology Internatnl Ltd (ADR) (NASDAQ:HSFT)
is the 14th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.7%
on the day. HSFTs upside potential is 81.8% based on brokerage analysts average
target price of $18.16. It is trading at 29.4% of its 52-week high of $34.00,
and 24.6% above its 52-week low of $8.02. Huaneng Power International, Inc.
(ADR) (NYSE:HNP) is the 15th best-performing U.S.-listed Chinese stock on Jan.
5. It was up 1.6% on the day. HNPs upside potential is 7.0% based on brokerage
analysts average target price of $23.32. It is trading at 91.1% of its 52-week
high of $23.94, and 41.1% above its 52-week low of $15.45. Melco Crown
Entertainment Ltd (ADR) (NASDAQ:MPEL) is the 16th best-performing U.S.-listed
Chinese stock on Jan. 5. It was up 1.6% on the day. MPELs upside potential is
54.0% based on brokerage analysts average target price of $15.37. It is trading
at 61.8% of its 52-week high of $16.15, and 54.5% above its 52-week low of
$6.46. E Commerce China Dangdang Inc (ADR) (NYSE:DANG) is the 17th
best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.5% on the day.
DANGs upside potential is 86.9% based on brokerage analysts average target price
of $9.83. It is trading at 14.5% of its 52-week high of $36.40, and 28.0% above
its 52-week low of $4.11. Mindray Medical International Ltd (ADR) (NYSE:MR) is
the 18th best-performing U.S.-listed Chinese stock on Jan. 5. It was up 1.5% on
the day. MRs upside potential is 17.9% based on brokerage analysts average
target price of $31.13. It is trading at 84.6% of its 52-week high of $31.21,
and 24.3% above its 52-week low of $21.25. Country Syl Ckng Restaurant Chain Co
Ltd (NYSE:CCSC) is the 19th best-performing U.S.-listed Chinese stock on Jan. 5.
It was up 1.4% on the day. CCSCs upside potential is 51.4% based on brokerage
analysts average target price of $12.12. It is trading at 31.8% of its 52-week
high of $25.19, and 21.4% above its 52-week low of $6.60. China Mobile Ltd.
(ADR) (NYSE:CHL) is the 20th best-performing U.S.-listed Chinese stock on Jan.
5. It was up 1.2% on the day. CHLs upside potential is 1.5% based on brokerage
analysts average target price of $49.97. It is trading at 94.7% of its 52-week
high of $51.98, and 13.1% above its 52-week low of $43.51.
Apple Inc. (NASDAQ:AAPL) To Extend iPhone 4S Reach
Apple Inc. (NASDAQ:AAPL) has decided to start selling the iPhone 4S in mainland
China from January 13 onwards. Apple Inc. (NASDAQ:AAPL) To Extend iPhone 4S
Reach According to an announcement made by the US based smartphone maker giant
Apple Inc. (NASDAQ:AAPL), it will start selling its latest iPhone 4S in mainland
China and 21 other countries from Jan. 13 onwards. Tim Cook, Apple Inc.
(NASDAQ:AAPL)'s chief executive officer said in a statement, "Customers
response to our products in China has been off the charts. With the launch in
China next week, iPhone 4S will be available in over 90 countries and regions,
making it Apples fastest iPhone rollout ever." The iPhone 4S has been seen as
an incremental improvement over its predecessor, but demand for the device from
consumers has been huge. Apple Inc. (NASDAQ:AAPL) stocks were at 413.44 at the
end of the last days trading. Theres been a 10.4% movement in the stock price
over the past 3 months. Apple Inc. (NASDAQ:AAPL) Analyst Advice Consensus
Opinion: Moderate Buy Mean recommendation: 1.17 (1=Strong Buy, 5=Strong Sell) 3
Months Ago: 1.21 Zacks Rank: 2 out of 2 in the industry
China from January 13 onwards. Apple Inc. (NASDAQ:AAPL) To Extend iPhone 4S
Reach According to an announcement made by the US based smartphone maker giant
Apple Inc. (NASDAQ:AAPL), it will start selling its latest iPhone 4S in mainland
China and 21 other countries from Jan. 13 onwards. Tim Cook, Apple Inc.
(NASDAQ:AAPL)'s chief executive officer said in a statement, "Customers
response to our products in China has been off the charts. With the launch in
China next week, iPhone 4S will be available in over 90 countries and regions,
making it Apples fastest iPhone rollout ever." The iPhone 4S has been seen as
an incremental improvement over its predecessor, but demand for the device from
consumers has been huge. Apple Inc. (NASDAQ:AAPL) stocks were at 413.44 at the
end of the last days trading. Theres been a 10.4% movement in the stock price
over the past 3 months. Apple Inc. (NASDAQ:AAPL) Analyst Advice Consensus
Opinion: Moderate Buy Mean recommendation: 1.17 (1=Strong Buy, 5=Strong Sell) 3
Months Ago: 1.21 Zacks Rank: 2 out of 2 in the industry
Dendreon Jumps 40% on Provenge Sales
It's early in the year, but it looks as though Dendreon (NASDAQ: DNDN ) is
making a serious bid to return to respectability. Shares of the Seattle-based
biotech firm soared almost 40% Thursday as the company reported that sales of
its cancer drug Provenge were about $82 million. That figure was more than both
analysts and the company itself expected. "We believe that the improved
reimbursement landscape, along with our improved sales execution and physician
education initiatives, are contributing to the increased use of Provenge in the
community urology and oncology settings," president and CEO Mitchell H. Gold
said in a company news release. "We had a strong fourth quarter that exceeded
our expectations. As we look to 2012, we expect modest quarter-over-quarter
growth while we focus on bringing additional clinics on board and converting
them into steady prescribers." At $10.62 a share, the company still has a
steep climb to reach the $54-plus price the shares were commanding in May 2010.
Even as recently as last August, Dendreon was trading at $35. That's when the
bottom fell out as the company dramatically cut its sales forecast for Provenge.
Disappointed investors abandoned the stock in droves, cutting the price by
two-thirds in a single day. Then in November, when Dendreon forecast that sales
of the drug that month would be lower than October's $26.4 million, investors
took the company to the whipping post once more, beating the price down to its
52-week low of $6.46. The outlook for the once heralded blockbuster looked grim,
indeed. Now, with full-year revenue of about nearly $230 million, Provenge and
Dendreon have been vindicated to some degree. "Theres a lot of exuberance
today," Joseph Pantginis, an analyst for Roth Capital Partners in New York,
told Bloomberg in a telephone interview. "The most important thing is that
people are gathering some comfort because they look like theyre on the right
track with regard to reimbursement. That had been a major overhang." David
Nierengarten, a San Francisco-based analyst with Wedbush Securities Inc., was
less sanguine about the drug's prospects. "A large source of the surprise
here is because they signed up more accounts than probably they, or anyone,
expected," he told Bloomberg . "But the repeat business here is not going to
sustain this kind of quarter-over-quarter growth in the future." Once seen as
a potential blockbuster, Provenge was approved in April 2010 as the first
therapy in the U.S. that trains the body's immune system to attack prostate
cancer cells as if they were a virus. The treatment, which costs $93,000, was
cleared for patients with advanced cases of the disease after Dendreon's
three-year effort to persuade the FDA to back the medicine. Concerns centering
on government reimbursement have dogged sales of Provenge. Doctors don't like
the fact that they have to lay out the $93,000, then wait for reimbursement from
payers. As of this writing, Barry Cohen did not hold a position in any of the
aforementioned stocks.
making a serious bid to return to respectability. Shares of the Seattle-based
biotech firm soared almost 40% Thursday as the company reported that sales of
its cancer drug Provenge were about $82 million. That figure was more than both
analysts and the company itself expected. "We believe that the improved
reimbursement landscape, along with our improved sales execution and physician
education initiatives, are contributing to the increased use of Provenge in the
community urology and oncology settings," president and CEO Mitchell H. Gold
said in a company news release. "We had a strong fourth quarter that exceeded
our expectations. As we look to 2012, we expect modest quarter-over-quarter
growth while we focus on bringing additional clinics on board and converting
them into steady prescribers." At $10.62 a share, the company still has a
steep climb to reach the $54-plus price the shares were commanding in May 2010.
Even as recently as last August, Dendreon was trading at $35. That's when the
bottom fell out as the company dramatically cut its sales forecast for Provenge.
Disappointed investors abandoned the stock in droves, cutting the price by
two-thirds in a single day. Then in November, when Dendreon forecast that sales
of the drug that month would be lower than October's $26.4 million, investors
took the company to the whipping post once more, beating the price down to its
52-week low of $6.46. The outlook for the once heralded blockbuster looked grim,
indeed. Now, with full-year revenue of about nearly $230 million, Provenge and
Dendreon have been vindicated to some degree. "Theres a lot of exuberance
today," Joseph Pantginis, an analyst for Roth Capital Partners in New York,
told Bloomberg in a telephone interview. "The most important thing is that
people are gathering some comfort because they look like theyre on the right
track with regard to reimbursement. That had been a major overhang." David
Nierengarten, a San Francisco-based analyst with Wedbush Securities Inc., was
less sanguine about the drug's prospects. "A large source of the surprise
here is because they signed up more accounts than probably they, or anyone,
expected," he told Bloomberg . "But the repeat business here is not going to
sustain this kind of quarter-over-quarter growth in the future." Once seen as
a potential blockbuster, Provenge was approved in April 2010 as the first
therapy in the U.S. that trains the body's immune system to attack prostate
cancer cells as if they were a virus. The treatment, which costs $93,000, was
cleared for patients with advanced cases of the disease after Dendreon's
three-year effort to persuade the FDA to back the medicine. Concerns centering
on government reimbursement have dogged sales of Provenge. Doctors don't like
the fact that they have to lay out the $93,000, then wait for reimbursement from
payers. As of this writing, Barry Cohen did not hold a position in any of the
aforementioned stocks.
Bold Day for Bank of America — Thursday’s IP Market Recap
Bank of America (NYSE: BAC ) has to be loving 2012 so far. The much-maligned
financial stock of 2011 led big U.S. banking stocks to a strong showing Thursday
that saw BAC shares rise above the $6 mark for the first time since early
November. Bank analyst Nancy Bush told Reuters that upbeat job data and the
possible anticipation of positive mortgage-related news propped up the bank's
shares. BAC stock popped about 8.6%, putting the stock up more than 13% in the
new year. Its giant American rivals enjoyed modest gains too, with JPMorgan
Chase (NYSE: JPM , +2.1%), Wells Fargo (NYSE: WFC , +1.6%) and Citigroup (NYSE:
C , +1.2%) all up on a flat day for the markets. A few automakers also pushed
forward Thursday as data continues to roll out from 2011 auto sales . The
Detroit "Big 3" were all profitable for the first time since 2004, with
Chrysler posting a 37% sales pop in December and Ford (NYSE: F ) and General
Motors (NYSE: GM ) posting more modest, but strong, gains. GM was up almost 5%,
and F shares gained about 2.6% Thursday. Volkswagen (PINK: VLKAY ) also got a
decent 1.5% boost, as it saw a monthly sales increase of 31%. Dendreon (NASDAQ:
DNDN ) made waves as one of the biggest market movers of the day, gaining almost
40% on better-than-expected sales of its cancer drug Provenge. The company
reported $82 million in fourth-quarter Provenge sales, and DNDN shares reached
their highest price in two months. Three Up Ancestry.com (NASDAQ: ACOM ): Up
20.1% ($4.60) to $27.47. ( ACOM and how to play the baby boom .) Sirius XM Radio
(NASDAQ: SIRI ): Up 11.5% (21 cents) to $2.04. Nokia (NYSE: NOK ): Up 6.5% (33
cents) to $5.41. Three Down Barnes & Noble (NYSE: BKS ): Down 17.1% ($2.31) to
$11.24. ( BKS consider selling off Nook business .) American Eagle (NYSE: AEO ):
Down 10.8% ($1.64) to $13.52. MetroPCS Communications (NYSE: PCS ): Down 8.9%
(78 cents) to $8.01. As of this writing, Kyle Woodley did not hold a position in
any of the aforementioned stocks. Check out our list of previous IP Market
Recaps .
financial stock of 2011 led big U.S. banking stocks to a strong showing Thursday
that saw BAC shares rise above the $6 mark for the first time since early
November. Bank analyst Nancy Bush told Reuters that upbeat job data and the
possible anticipation of positive mortgage-related news propped up the bank's
shares. BAC stock popped about 8.6%, putting the stock up more than 13% in the
new year. Its giant American rivals enjoyed modest gains too, with JPMorgan
Chase (NYSE: JPM , +2.1%), Wells Fargo (NYSE: WFC , +1.6%) and Citigroup (NYSE:
C , +1.2%) all up on a flat day for the markets. A few automakers also pushed
forward Thursday as data continues to roll out from 2011 auto sales . The
Detroit "Big 3" were all profitable for the first time since 2004, with
Chrysler posting a 37% sales pop in December and Ford (NYSE: F ) and General
Motors (NYSE: GM ) posting more modest, but strong, gains. GM was up almost 5%,
and F shares gained about 2.6% Thursday. Volkswagen (PINK: VLKAY ) also got a
decent 1.5% boost, as it saw a monthly sales increase of 31%. Dendreon (NASDAQ:
DNDN ) made waves as one of the biggest market movers of the day, gaining almost
40% on better-than-expected sales of its cancer drug Provenge. The company
reported $82 million in fourth-quarter Provenge sales, and DNDN shares reached
their highest price in two months. Three Up Ancestry.com (NASDAQ: ACOM ): Up
20.1% ($4.60) to $27.47. ( ACOM and how to play the baby boom .) Sirius XM Radio
(NASDAQ: SIRI ): Up 11.5% (21 cents) to $2.04. Nokia (NYSE: NOK ): Up 6.5% (33
cents) to $5.41. Three Down Barnes & Noble (NYSE: BKS ): Down 17.1% ($2.31) to
$11.24. ( BKS consider selling off Nook business .) American Eagle (NYSE: AEO ):
Down 10.8% ($1.64) to $13.52. MetroPCS Communications (NYSE: PCS ): Down 8.9%
(78 cents) to $8.01. As of this writing, Kyle Woodley did not hold a position in
any of the aforementioned stocks. Check out our list of previous IP Market
Recaps .
Gold Resource Corp (GORO) Shares Cross Above 200 DMA
Gold Resource Corp (GORO) Shares Cross Above 200 DMA MarketNewsVideo.com - 2
hours ago By Market News Video Staff, Thursday, January 5, 4:26 PM ET In trading
on Thursday, shares of Gold Resource Corp (AMEX:GORO) crossed above their 200
day moving average of $23.91, changing hands as ...
hours ago By Market News Video Staff, Thursday, January 5, 4:26 PM ET In trading
on Thursday, shares of Gold Resource Corp (AMEX:GORO) crossed above their 200
day moving average of $23.91, changing hands as ...
Top Oversold U.S.-Listed Chinese Stocks (Jan 05, 2012)
Below are the latest oversold U.S.-listed Chinese stocks. 51job, Inc. (ADR)
(NASDAQ:JOBS) is the most oversold U.S.-listed Chinese stock on Jan. 05. It was
down 5.2% on the day. JOBSs upside potential is 64.1% based on brokerage
analysts average target price of $64.50. It is trading at 56.3% of its 52-week
high of $69.80, and 7.3% above its 52-week low of $36.62. Jiayuan.com
International Ltd (NASDAQ:DATE) is the second most oversold U.S.-listed Chinese
stock on Jan. 05. It was down 3.8% on the day. DATEs upside potential is 161.9%
based on brokerage analysts average target price of $15.22. It is trading at
36.0% of its 52-week high of $16.12, and 5.6% above its 52-week low of $5.50.
China Lodging Group, Ltd (ADR) (NASDAQ:HTHT) is the third most oversold
U.S.-listed Chinese stock on Jan. 05. It was down 3.8% on the day. HTHTs upside
potential is 64.3% based on brokerage analysts average target price of $21.82.
It is trading at 54.3% of its 52-week high of $24.47, and 10.7% above its
52-week low of $12.00. Simcere Pharmaceutical Group (ADR) (NYSE:SCR) is the
fourth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 3.7% on
the day. SCRs upside potential is 9.7% based on brokerage analysts average
target price of $9.98. It is trading at 66.2% of its 52-week high of $13.75, and
27.8% above its 52-week low of $7.12. Focus Media Holding Limited (ADR)
(NASDAQ:FMCN) is the fifth most oversold U.S.-listed Chinese stock on Jan. 05.
It was down 3.3% on the day. FMCNs upside potential is 104.2% based on brokerage
analysts average target price of $40.23. It is trading at 52.4% of its 52-week
high of $37.58, and 124.1% above its 52-week low of $8.79. Spreadtrum
Communications, Inc (ADR) (NASDAQ:SPRD) is the sixth most oversold U.S.-listed
Chinese stock on Jan. 05. It was down 2.9% on the day. SPRDs upside potential is
58.8% based on brokerage analysts average target price of $30.58. It is trading
at 64.2% of its 52-week high of $29.98, and 124.2% above its 52-week low of
$8.59. Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) is the seventh most
oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.4% on the day.
CTRPs upside potential is 88.4% based on brokerage analysts average target price
of $44.30. It is trading at 46.5% of its 52-week high of $50.57, and 5.3% above
its 52-week low of $22.33. ReneSola Ltd. (ADR) (NYSE:SOL) is the eighth most
oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.4% on the day. SOLs
upside potential is 76.6% based on brokerage analysts average target price of
$2.86. It is trading at 12.2% of its 52-week high of $13.25, and 11.7% above its
52-week low of $1.45. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) is the
ninth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.2% on
the day. YGEs upside potential is 33.8% based on brokerage analysts average
target price of $5.29. It is trading at 29.1% of its 52-week high of $13.59, and
43.6% above its 52-week low of $2.75. AutoNavi Holdings Ltd (ADR) (NASDAQ:AMAP)
is the 10th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.7%
on the day. AMAPs upside potential is 137.8% based on brokerage analysts average
target price of $22.83. It is trading at 47.5% of its 52-week high of $20.20,
and 8.2% above its 52-week low of $8.87. Home Inns & Hotels Management Inc.
(ADR) (NASDAQ:HMIN) is the 11th most oversold U.S.-listed Chinese stock on Jan.
05. It was down 1.4% on the day. HMINs upside potential is 83.8% based on
brokerage analysts average target price of $47.69. It is trading at 57.8% of its
52-week high of $44.86, and 17.4% above its 52-week low of $22.09. Suntech Power
Holdings Co., Ltd. (ADR) (NYSE:STP) is the 12th most oversold U.S.-listed
Chinese stock on Jan. 05. It was down 1.2% on the day. STPs upside potential is
84.7% based on brokerage analysts average target price of $4.43. It is trading
at 22.2% of its 52-week high of $10.83, and 41.2% above its 52-week low of
$1.70. Noah Holdings Limited (ADR) (NYSE:NOAH) is the 13th most oversold
U.S.-listed Chinese stock on Jan. 05. It was down 1.2% on the day. NOAHs upside
potential is 232.8% based on brokerage analysts average target price of $19.96.
It is trading at 30.9% of its 52-week high of $19.40, and 4.7% above its 52-week
low of $5.73. SINA Corporation (USA) (NASDAQ:SINA) is the 14th most oversold
U.S.-listed Chinese stock on Jan. 05. It was down 1.1% on the day. SINAs upside
potential is 98.9% based on brokerage analysts average target price of $105.37.
It is trading at 36.0% of its 52-week high of $147.12, and 13.0% above its
52-week low of $46.86. Shanda Games Limited(ADR) (NASDAQ:GAME) is the 15th most
oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.0% on the day.
GAMEs upside potential is 61.9% based on brokerage analysts average target price
of $6.65. It is trading at 53.4% of its 52-week high of $7.70, and 18.8% above
its 52-week low of $3.46. China Real Estate Information Corp (NASDAQ:CRIC) is
the 16th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.9% on
the day. CRICs upside potential is 89.0% based on brokerage analysts average
target price of $8.05. It is trading at 45.9% of its 52-week high of $9.29, and
15.8% above its 52-week low of $3.68. Trina Solar Limited (ADR) (NYSE:TSL) is
the 17th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.9% on
the day. TSLs upside potential is 86.4% based on brokerage analysts average
target price of $13.07. It is trading at 22.6% of its 52-week high of $31.08,
and 32.8% above its 52-week low of $5.28. AsiaInfo-Linkage, Inc. (NASDAQ:ASIA)
is the 18th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.8%
on the day. ASIAs upside potential is 131.5% based on brokerage analysts average
target price of $17.44. It is trading at 32.9% of its 52-week high of $22.91,
and 21.3% above its 52-week low of $6.21. 21Vianet Group Inc (NASDAQ:VNET) is
the 19th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.8% on
the day. VNETs upside potential is 91.9% based on brokerage analysts average
target price of $17.89. It is trading at 41.7% of its 52-week high of $22.33,
and 12.2% above its 52-week low of $8.31. JA Solar Holdings Co., Ltd. (ADR)
(NASDAQ:JASO) is the 20th most oversold U.S.-listed Chinese stock on Jan. 05. It
was down 0.7% on the day. JASOs upside potential is 131.2% based on brokerage
analysts average target price of $3.14. It is trading at 15.9% of its 52-week
high of $8.57, and 12.4% above its 52-week low of $1.21.
(NASDAQ:JOBS) is the most oversold U.S.-listed Chinese stock on Jan. 05. It was
down 5.2% on the day. JOBSs upside potential is 64.1% based on brokerage
analysts average target price of $64.50. It is trading at 56.3% of its 52-week
high of $69.80, and 7.3% above its 52-week low of $36.62. Jiayuan.com
International Ltd (NASDAQ:DATE) is the second most oversold U.S.-listed Chinese
stock on Jan. 05. It was down 3.8% on the day. DATEs upside potential is 161.9%
based on brokerage analysts average target price of $15.22. It is trading at
36.0% of its 52-week high of $16.12, and 5.6% above its 52-week low of $5.50.
China Lodging Group, Ltd (ADR) (NASDAQ:HTHT) is the third most oversold
U.S.-listed Chinese stock on Jan. 05. It was down 3.8% on the day. HTHTs upside
potential is 64.3% based on brokerage analysts average target price of $21.82.
It is trading at 54.3% of its 52-week high of $24.47, and 10.7% above its
52-week low of $12.00. Simcere Pharmaceutical Group (ADR) (NYSE:SCR) is the
fourth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 3.7% on
the day. SCRs upside potential is 9.7% based on brokerage analysts average
target price of $9.98. It is trading at 66.2% of its 52-week high of $13.75, and
27.8% above its 52-week low of $7.12. Focus Media Holding Limited (ADR)
(NASDAQ:FMCN) is the fifth most oversold U.S.-listed Chinese stock on Jan. 05.
It was down 3.3% on the day. FMCNs upside potential is 104.2% based on brokerage
analysts average target price of $40.23. It is trading at 52.4% of its 52-week
high of $37.58, and 124.1% above its 52-week low of $8.79. Spreadtrum
Communications, Inc (ADR) (NASDAQ:SPRD) is the sixth most oversold U.S.-listed
Chinese stock on Jan. 05. It was down 2.9% on the day. SPRDs upside potential is
58.8% based on brokerage analysts average target price of $30.58. It is trading
at 64.2% of its 52-week high of $29.98, and 124.2% above its 52-week low of
$8.59. Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) is the seventh most
oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.4% on the day.
CTRPs upside potential is 88.4% based on brokerage analysts average target price
of $44.30. It is trading at 46.5% of its 52-week high of $50.57, and 5.3% above
its 52-week low of $22.33. ReneSola Ltd. (ADR) (NYSE:SOL) is the eighth most
oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.4% on the day. SOLs
upside potential is 76.6% based on brokerage analysts average target price of
$2.86. It is trading at 12.2% of its 52-week high of $13.25, and 11.7% above its
52-week low of $1.45. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) is the
ninth most oversold U.S.-listed Chinese stock on Jan. 05. It was down 2.2% on
the day. YGEs upside potential is 33.8% based on brokerage analysts average
target price of $5.29. It is trading at 29.1% of its 52-week high of $13.59, and
43.6% above its 52-week low of $2.75. AutoNavi Holdings Ltd (ADR) (NASDAQ:AMAP)
is the 10th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.7%
on the day. AMAPs upside potential is 137.8% based on brokerage analysts average
target price of $22.83. It is trading at 47.5% of its 52-week high of $20.20,
and 8.2% above its 52-week low of $8.87. Home Inns & Hotels Management Inc.
(ADR) (NASDAQ:HMIN) is the 11th most oversold U.S.-listed Chinese stock on Jan.
05. It was down 1.4% on the day. HMINs upside potential is 83.8% based on
brokerage analysts average target price of $47.69. It is trading at 57.8% of its
52-week high of $44.86, and 17.4% above its 52-week low of $22.09. Suntech Power
Holdings Co., Ltd. (ADR) (NYSE:STP) is the 12th most oversold U.S.-listed
Chinese stock on Jan. 05. It was down 1.2% on the day. STPs upside potential is
84.7% based on brokerage analysts average target price of $4.43. It is trading
at 22.2% of its 52-week high of $10.83, and 41.2% above its 52-week low of
$1.70. Noah Holdings Limited (ADR) (NYSE:NOAH) is the 13th most oversold
U.S.-listed Chinese stock on Jan. 05. It was down 1.2% on the day. NOAHs upside
potential is 232.8% based on brokerage analysts average target price of $19.96.
It is trading at 30.9% of its 52-week high of $19.40, and 4.7% above its 52-week
low of $5.73. SINA Corporation (USA) (NASDAQ:SINA) is the 14th most oversold
U.S.-listed Chinese stock on Jan. 05. It was down 1.1% on the day. SINAs upside
potential is 98.9% based on brokerage analysts average target price of $105.37.
It is trading at 36.0% of its 52-week high of $147.12, and 13.0% above its
52-week low of $46.86. Shanda Games Limited(ADR) (NASDAQ:GAME) is the 15th most
oversold U.S.-listed Chinese stock on Jan. 05. It was down 1.0% on the day.
GAMEs upside potential is 61.9% based on brokerage analysts average target price
of $6.65. It is trading at 53.4% of its 52-week high of $7.70, and 18.8% above
its 52-week low of $3.46. China Real Estate Information Corp (NASDAQ:CRIC) is
the 16th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.9% on
the day. CRICs upside potential is 89.0% based on brokerage analysts average
target price of $8.05. It is trading at 45.9% of its 52-week high of $9.29, and
15.8% above its 52-week low of $3.68. Trina Solar Limited (ADR) (NYSE:TSL) is
the 17th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.9% on
the day. TSLs upside potential is 86.4% based on brokerage analysts average
target price of $13.07. It is trading at 22.6% of its 52-week high of $31.08,
and 32.8% above its 52-week low of $5.28. AsiaInfo-Linkage, Inc. (NASDAQ:ASIA)
is the 18th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.8%
on the day. ASIAs upside potential is 131.5% based on brokerage analysts average
target price of $17.44. It is trading at 32.9% of its 52-week high of $22.91,
and 21.3% above its 52-week low of $6.21. 21Vianet Group Inc (NASDAQ:VNET) is
the 19th most oversold U.S.-listed Chinese stock on Jan. 05. It was down 0.8% on
the day. VNETs upside potential is 91.9% based on brokerage analysts average
target price of $17.89. It is trading at 41.7% of its 52-week high of $22.33,
and 12.2% above its 52-week low of $8.31. JA Solar Holdings Co., Ltd. (ADR)
(NASDAQ:JASO) is the 20th most oversold U.S.-listed Chinese stock on Jan. 05. It
was down 0.7% on the day. JASOs upside potential is 131.2% based on brokerage
analysts average target price of $3.14. It is trading at 15.9% of its 52-week
high of $8.57, and 12.4% above its 52-week low of $1.21.
Dendreon Jumps 30% on Provenge Sales
It's early in the year, but it looks as though Dendreon (NASDAQ: DNDN ) is
making a serious bid to return to respectability. Shares of the Seattle-based
biotech firm soared more than 30% Thursday as the company reported that sales of
its cancer drug Provenge were about $82 million. That figure was more than both
analysts and the company itself expected. "We believe that the improved
reimbursement landscape, along with our improved sales execution and physician
education initiatives, are contributing to the increased use of Provenge in the
community urology and oncology settings," president and CEO Mitchell H. Gold
said in a company news release. "We had a strong fourth quarter that exceeded
our expectations. As we look to 2012, we expect modest quarter-over-quarter
growth while we focus on bringing additional clinics on board and converting
them into steady prescribers." At $10.46 a share, the company still has a
steep climb to reach the $54-plus price the shares were commanding in May 2010.
Even as recently as last August, Dendreon was trading at $35. That's when the
bottom fell out as the company dramatically cut its sales forecast for Provenge.
Disappointed investors abandoned the stock in droves, cutting the price by
two-thirds in a single day. Then in November, when Dendreon forecast that sales
of the drug that month would be lower than October's $26.4 million, investors
took the company to the whipping post once more, beating the price down to its
52-week low of $6.46. The outlook for the once heralded blockbuster looked grim,
indeed. Now, with full-year revenue of about nearly $230 million, Provenge and
Dendreon have been vindicated to some degree. "Theres a lot of exuberance
today," Joseph Pantginis, an analyst for Roth Capital Partners in New York,
told Bloomberg in a telephone interview. "The most important thing is that
people are gathering some comfort because they look like theyre on the right
track with regard to reimbursement. That had been a major overhang." David
Nierengarten, a San Francisco-based analyst with Wedbush Securities Inc., was
less sanguine about the drug's prospects. "A large source of the surprise
here is because they signed up more accounts than probably they, or anyone,
expected," he told Bloomberg . "But the repeat business here is not going to
sustain this kind of quarter-over-quarter growth in the future." Once seen as
a potential blockbuster, Provenge was approved in April 2010 as the first
therapy in the U.S. that trains the body's immune system to attack prostate
cancer cells as if they were a virus. The treatment, which costs $93,000, was
cleared for patients with advanced cases of the disease after Dendreon's
three-year effort to persuade the FDA to back the medicine. Concerns centering
on government reimbursement have dogged sales of Provenge. Doctors don't like
the fact that they have to lay out the $93,000, then wait for reimbursement from
payers. As of this writing, Barry Cohen did not hold a position in any of the
aforementioned stocks.
making a serious bid to return to respectability. Shares of the Seattle-based
biotech firm soared more than 30% Thursday as the company reported that sales of
its cancer drug Provenge were about $82 million. That figure was more than both
analysts and the company itself expected. "We believe that the improved
reimbursement landscape, along with our improved sales execution and physician
education initiatives, are contributing to the increased use of Provenge in the
community urology and oncology settings," president and CEO Mitchell H. Gold
said in a company news release. "We had a strong fourth quarter that exceeded
our expectations. As we look to 2012, we expect modest quarter-over-quarter
growth while we focus on bringing additional clinics on board and converting
them into steady prescribers." At $10.46 a share, the company still has a
steep climb to reach the $54-plus price the shares were commanding in May 2010.
Even as recently as last August, Dendreon was trading at $35. That's when the
bottom fell out as the company dramatically cut its sales forecast for Provenge.
Disappointed investors abandoned the stock in droves, cutting the price by
two-thirds in a single day. Then in November, when Dendreon forecast that sales
of the drug that month would be lower than October's $26.4 million, investors
took the company to the whipping post once more, beating the price down to its
52-week low of $6.46. The outlook for the once heralded blockbuster looked grim,
indeed. Now, with full-year revenue of about nearly $230 million, Provenge and
Dendreon have been vindicated to some degree. "Theres a lot of exuberance
today," Joseph Pantginis, an analyst for Roth Capital Partners in New York,
told Bloomberg in a telephone interview. "The most important thing is that
people are gathering some comfort because they look like theyre on the right
track with regard to reimbursement. That had been a major overhang." David
Nierengarten, a San Francisco-based analyst with Wedbush Securities Inc., was
less sanguine about the drug's prospects. "A large source of the surprise
here is because they signed up more accounts than probably they, or anyone,
expected," he told Bloomberg . "But the repeat business here is not going to
sustain this kind of quarter-over-quarter growth in the future." Once seen as
a potential blockbuster, Provenge was approved in April 2010 as the first
therapy in the U.S. that trains the body's immune system to attack prostate
cancer cells as if they were a virus. The treatment, which costs $93,000, was
cleared for patients with advanced cases of the disease after Dendreon's
three-year effort to persuade the FDA to back the medicine. Concerns centering
on government reimbursement have dogged sales of Provenge. Doctors don't like
the fact that they have to lay out the $93,000, then wait for reimbursement from
payers. As of this writing, Barry Cohen did not hold a position in any of the
aforementioned stocks.
Microsoft Corporation (NASDAQ:MSFT) Signs Games Developer Deal
Microsoft Corporation (NASDAQ:MSFT) has inked a deal with Arkadium. Microsoft
Corporation (NASDAQ:MSFT) Signs Games Developer Deal Reports say that Microsoft
Corporation (NASDAQ:MSFT) Game Studios have partnered with social games
developer, Arkadium to develop casual and social games on multiple platforms.
The multi-year, multi-title strategic partnership brings the two companies
together to work on cross-platform games for Microsoft platforms, including
Windows PC and mobile devices. Kenny Rosenblatt, Arkadium CEO Said that,
Arkadium and Microsoft Corporation (NASDAQ:MSFT) have been partners for several
years now. Arkadium has been the largest provider of games to Microsoft
Corporation (NASDAQ:MSFT)s web properties like Bing, MSN Zone and MSN Messenger
for the last several years, with titles consistently on the top of those
services most-played or most-popular lists. As the relationship got stronger and
the games became more popular, that led to a bigger opportunity with the
Microsoft Corporation (NASDAQ:MSFT) Game Studios team, which really has been
focused on the Xbox and on more hardcore console games". Microsoft Corp.
(NASDAQ:MSFT) shares are currently standing at 27.4. Price History Last Price:
27.4 52 Week Low / High: 23.65 / 29.46 50 Day Moving Average: 25.95 6 Month
Price Change %: 2.8% 12 Month Price Change %: -4.3%
Corporation (NASDAQ:MSFT) Signs Games Developer Deal Reports say that Microsoft
Corporation (NASDAQ:MSFT) Game Studios have partnered with social games
developer, Arkadium to develop casual and social games on multiple platforms.
The multi-year, multi-title strategic partnership brings the two companies
together to work on cross-platform games for Microsoft platforms, including
Windows PC and mobile devices. Kenny Rosenblatt, Arkadium CEO Said that,
Arkadium and Microsoft Corporation (NASDAQ:MSFT) have been partners for several
years now. Arkadium has been the largest provider of games to Microsoft
Corporation (NASDAQ:MSFT)s web properties like Bing, MSN Zone and MSN Messenger
for the last several years, with titles consistently on the top of those
services most-played or most-popular lists. As the relationship got stronger and
the games became more popular, that led to a bigger opportunity with the
Microsoft Corporation (NASDAQ:MSFT) Game Studios team, which really has been
focused on the Xbox and on more hardcore console games". Microsoft Corp.
(NASDAQ:MSFT) shares are currently standing at 27.4. Price History Last Price:
27.4 52 Week Low / High: 23.65 / 29.46 50 Day Moving Average: 25.95 6 Month
Price Change %: 2.8% 12 Month Price Change %: -4.3%
IP.com Readers Bullish on 2012
Like riders white-knuckling it on an explosive mega-coaster (Six Flags' Nitro
comes to mind), investors were taken on a wild ride in 2011. The market blasted
up and plunged down in dizzying intervals only to end up right back where it
started. Yet, despite the whiplash, the year finished decidedly flat the Dow
saw a measly 5.5% gain, the Nasdaq lost 1% and the S&P 500 was essentially
unchanged. With 2011's lackluster results under our belt, we wanted to know
how our readers were feeling about the market year ahead. So we asked: "How do
you think the S&P 500 will perform in 2012?" The response was bullish. More
than half of the 1,285 poll takers (nearly 55%) expect the S&P to be "up" or
"significantly up" at year-end, 30% say "relatively flat" and 15%
predict the S&P will be "down" or "significantly down" for the year.
Here are the details of how the poll vote shook out:
comes to mind), investors were taken on a wild ride in 2011. The market blasted
up and plunged down in dizzying intervals only to end up right back where it
started. Yet, despite the whiplash, the year finished decidedly flat the Dow
saw a measly 5.5% gain, the Nasdaq lost 1% and the S&P 500 was essentially
unchanged. With 2011's lackluster results under our belt, we wanted to know
how our readers were feeling about the market year ahead. So we asked: "How do
you think the S&P 500 will perform in 2012?" The response was bullish. More
than half of the 1,285 poll takers (nearly 55%) expect the S&P to be "up" or
"significantly up" at year-end, 30% say "relatively flat" and 15%
predict the S&P will be "down" or "significantly down" for the year.
Here are the details of how the poll vote shook out:
Top 10 Real Estate Stocks with Highest Dividend Yield: APSA, SFUN, NEN, ARCP, APTS, CCG, MIM, NLP, EJ, WPC (Jan 05, 2012)
Below are the top 10 Real Estate stocks with highest dividend yields. Two
Chinese companies (SFUN, EJ) are on the list. Alto Palermo S.A. (ADR)
(NASDAQ:APSA) has the 1st highest dividend yield in this segment of the market.
Its current dividend yield is 13.56%. Its dividend payout ratio was 43.37% for
the last 12 months. SouFun Holdings Limited (ADR) (NYSE:SFUN) has the 2nd
highest dividend yield in this segment of the market. Its current dividend yield
is 13.52%. Its dividend payout ratio was N/A for the last 12 months. New England
Realty Associates LP (AMEX:NEN) has the 3rd highest dividend yield in this
segment of the market. Its current dividend yield is 11.67%. Its dividend payout
ratio was 312.14% for the last 12 months. American Realty Capital Properties Inc
(NASDAQ:ARCP) has the 4th highest dividend yield in this segment of the market.
Its current dividend yield is 8.42%. Its dividend payout ratio was N/A for the
last 12 months. Preferred Apartment Communities Inc. (AMEX:APTS) has the 5th
highest dividend yield in this segment of the market. Its current dividend yield
is 8.26%. Its dividend payout ratio was N/A for the last 12 months. Campus Crest
Communities Inc (NYSE:CCG) has the 6th highest dividend yield in this segment of
the market. Its current dividend yield is 6.25%. Its dividend payout ratio was
N/A for the last 12 months. MI Developments Inc. (USA) (NYSE:MIM) has the 7th
highest dividend yield in this segment of the market. Its current dividend yield
is 6.12%. Its dividend payout ratio was N/A for the last 12 months. NTS Realty
Holdings LP (AMEX:NLP) has the 8th highest dividend yield in this segment of the
market. Its current dividend yield is 5.97%. Its dividend payout ratio was N/A
for the last 12 months. E-House (China) Holdings Limited (ADR) (NYSE:EJ) has the
9th highest dividend yield in this segment of the market. Its current dividend
yield is 5.39%. Its dividend payout ratio was N/A for the last 12 months. W. P.
Carey & Co. LLC (NYSE:WPC) has the 10th highest dividend yield in this segment
of the market. Its current dividend yield is 5.32%. Its dividend payout ratio
was 57.97% for the last 12 months.
Chinese companies (SFUN, EJ) are on the list. Alto Palermo S.A. (ADR)
(NASDAQ:APSA) has the 1st highest dividend yield in this segment of the market.
Its current dividend yield is 13.56%. Its dividend payout ratio was 43.37% for
the last 12 months. SouFun Holdings Limited (ADR) (NYSE:SFUN) has the 2nd
highest dividend yield in this segment of the market. Its current dividend yield
is 13.52%. Its dividend payout ratio was N/A for the last 12 months. New England
Realty Associates LP (AMEX:NEN) has the 3rd highest dividend yield in this
segment of the market. Its current dividend yield is 11.67%. Its dividend payout
ratio was 312.14% for the last 12 months. American Realty Capital Properties Inc
(NASDAQ:ARCP) has the 4th highest dividend yield in this segment of the market.
Its current dividend yield is 8.42%. Its dividend payout ratio was N/A for the
last 12 months. Preferred Apartment Communities Inc. (AMEX:APTS) has the 5th
highest dividend yield in this segment of the market. Its current dividend yield
is 8.26%. Its dividend payout ratio was N/A for the last 12 months. Campus Crest
Communities Inc (NYSE:CCG) has the 6th highest dividend yield in this segment of
the market. Its current dividend yield is 6.25%. Its dividend payout ratio was
N/A for the last 12 months. MI Developments Inc. (USA) (NYSE:MIM) has the 7th
highest dividend yield in this segment of the market. Its current dividend yield
is 6.12%. Its dividend payout ratio was N/A for the last 12 months. NTS Realty
Holdings LP (AMEX:NLP) has the 8th highest dividend yield in this segment of the
market. Its current dividend yield is 5.97%. Its dividend payout ratio was N/A
for the last 12 months. E-House (China) Holdings Limited (ADR) (NYSE:EJ) has the
9th highest dividend yield in this segment of the market. Its current dividend
yield is 5.39%. Its dividend payout ratio was N/A for the last 12 months. W. P.
Carey & Co. LLC (NYSE:WPC) has the 10th highest dividend yield in this segment
of the market. Its current dividend yield is 5.32%. Its dividend payout ratio
was 57.97% for the last 12 months.
2012 “Top Names for Potential M&A” in the Gold Sector
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 While gold shares as a group experienced a particularly difficult year in 2011, many junior gold stocks were the hardest hit in the sector.
Precious Metals Rebound, Gold and Silver Shares Climb
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Precious metals rebounded Thursday from earlier losses as the broader financial markets returned to positive territory in afternoon trading. COMEX gold futures fell below $1,600 per ounce this morning but later climbed toward $1,625, while silver bounced back from $28.69 to trade higher by 1.0% at $29.37 per ounce. The rebound in precious metals was not accompanied by weakness in the U.S. dollar, however, as the greenback maintained the large majority of its gains against a composite of foreign currencies.
2011 Emerging Market Telecom Ups and Downs
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace In a year that wasn’t kind to emerging markets, China Mobile (NYSE: CHL ) has done remarkably well since I recommended it in June — up around a modest 7%. But considering that many emerging markets are down around 20% since June — based on figures from the iShares MSCI Emerging Markets Index (ETF) (NYSE: EEM ) and the Vanguard MSCI Emerging Markets ETF (NYSE: VWO ) — I see no cause for complaint. My other notable mobile telecom provider, Turkcell (NYSE: TKC ) is a different story. Turkcell ended 2011 down 31.35%. This was enough to erase my prior gains and leave me with a loss of 12% since I first recommended the stock in May of 2010. It stings to watch gains evaporate like that. But I encourage investors to give this stock a little more time. The company got hit by a perfect storm in 2011, one that I did not fully appreciate until it was too late. Wedged between Europe and the Middle East, Turkey shares borders with the two crisis regions of 2011. With a banking crisis on one side and the Arab Spring on the other, you can't blame investors for getting nervous and bailing on the country. A surge in inflation certainly didn't help either. And in the case of Turkcell, a power struggle on the board of directors that resembled something out of a soap opera caused the company to delay its dividend payment for the year. Nevertheless, I continue to love Turkcell's fundamentals. The company is the dominant mobile provider in Turkey, one of the most promising emerging markets, and has a dominant position is several other countries in the region. Turkcell is also consistently ranked as one of the best-managed companies in Europe — something that would have certainly made Ataturk, the Western-leaning founder of the country, proud. I see investors returning to emerging markets in 2012 and to Turkey in particular. I also see Turkcell’s board drama getting resolved in the first quarter and the dividend being reinstated. I have enough faith in Turkcell to make it my choice in the InvestorPlace " 10 Best Stocks for 2012 " contest. Lastly, the one stock I was most disappointed with in 2011 was Cellcom Israel (NYSE: CEL ) , which ended the year down 48%. As with Turkcell, part of the problem was geography. Israeli stocks have done poorly ever since the Arab Spring broke out. Escalating tensions with Iran didn’t help much either. In investors' minds, it doesn't matter how great your cellular service is if Iranian bombs
Analyst Actions on Chinese Stocks: CEO, CHA, CHL, CHU, HTHT, LDK, NQ, PTR … (Jan 5, 2012)
XCSFDHG46767FHJHJF
tdp2664 China Analyst Below are the latest
Health Care IT Provider Cerner Is a Game-Changer
XCSFDHG46767FHJHJF
tdp2664 InvestorPlace Cerner (NASDAQ: CERN ) provides a platform to make electronic recordkeeping easy, hand-held and available across all the platforms of medical research, patient care, pharmaceutical/medication management and billing. The company has a very solid growth record and should continue to grow rapidly for several years. Cerner's software manages various processes for health care organizations of all sizes, from solo practitioners to large health care systems to entire countries. Approximately 9,000 medical providers/facilities use the company's platform, including 2,600 hospitals, 3,500 physician practices covering more than 30,000 physicians, 500 ambulatory facilities (such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers), 800 home health facilities and 1,600 retail pharmacies. The company's main software is called Cerner Millennium, and it runs on standard computer hardware. In fact, Cerner has relationships with Dell (NASDAQ: DELL ), Hewlett-Packard (NYSE: HPQ ) and IBM (NYSE: IBM ) so its customers can buy hardware at a discount. Cerner Millennium allows health care professionals to access a patient's electronic health record at point of care. They get up-to-date patient information in real time, complete with decision-support tools for physicians and nurses. Woven into the software are prompts that allow for ordering, documentation and billing. Just one example of this software's use is the emergency room, where the hectic pace is ripe for error and inefficiency. For this critical area of care, Cerner offers a triage and tracking board that shows doctors which patients are most in need of immediate care. Cerner's software also can improve the awful waiting times by identifying activities required in the ER and highlighting potential delays. On the business side, Cerner's solutions allow physicians to quickly complete documentation to ensure proper coding for billing. Cerner has a steady "razor and blades" model — sales of the software itself are the razor, and ongoing maintenance and service sales are the blades. This is significant, as virtually all of Cerner's software customers enter into maintenance agreements to support their systems. These agreements also give clients access to new releases of software covered by the agreements. Through the first nine months of 2011, software sales brought in 31% of revenues, services accounted for 41% and maintenance contributed 26%. That's a sizable chunk of recurring maintenance and service revenues, which helps give the company strong visibility into earnings and also should continue to grow as more Millennium systems are installed. In addition to the strong secular winds at the company's back, Cerner has internal initiatives to drive growth, including a Powerchart mobile device that may further encourage physicians to adopt EHRs. The company also should realize initial revenues from their Healthe (yes, that is the way they spell it) Intent cloud-based platform in 2012. Longer-term, the company should gain market share in the U.S. thanks to its strong product offerings, and CERN believes it can boost sales to existing clients with ancillary services. International revenues also should be a strong area of growth, as they currently account for just more than 10% of revenues. Accelerating Growth Cerner's revenues increased from $1.378 billion in 2006 to $1.85 billion in 2010, nearly 35% over the five-year period. However, growth began to accelerate in 2010, when revenues increased 10.6%, due in large part to the HITECH Act. Through the first three quarters of 2011, sales grew 18%, including a 24% jump in the third quarter. You can see the momentum building, and the outlook for continued growth looks bright with the order backlog at $5.65 billion at Oct. 1, 2011, up from $4.66 billion the year before. I like how successful the company has been in leveraging the sales growth into higher earnings. Operating earnings rose 23% in 2010, even though gross margins were flat from 2009, because operating expenses rose 7% compared with the 11% increase in revenues. That enabled earnings in 2010 to grow 20.3% to $1.39 per share. The trend was even more pronounced in the first nine months of last year as operating expenses grew 10% while revenues more than compensated with a 23% gain. As a result, operating earnings and earnings per share were both up 26%. Consensus estimates call for earnings (pro forma) in 2012 to increase 22% to $2.25 a share from $1.84 in 2011. These are very realistic expectations that could prove conservative given the strong momentum and large backlog. It's also very realistic to expect an additional 20% or more in 2013. The stock was a strong performer in 2011, gaining 29% for the year. However, it has pulled back from its high of $74.39 a little more than three months ago, which gives investors an opportunity to buy low. I look for the stock to outperform again in 2012, and investors will continue to reward it with a high P/E thanks to its excellent growth visibility over the next several years.
Gold & Silver Prices – Daily Outlook January 5
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Following the sharp gains recorded on the first business day of 2012 for both gold and silver prices, gold price continued to rise while silver price changed direction and moderately declined.
Gold and Crude Oil Continued to Trade Up –Recap January 4
XCSFDHG46767FHJHJF
DG365FD46564GFH654FU898 Gold price continued to rally and rose for the second consecutive day while silver prices changed direction and moderately declined; crude oil continued to trade up, while natural gas spot price declined. Major currencies such as Euro and Australian dollar changed direction and depreciated against the U.S dollar. Here is a summary of the price developments of precious metals and energy commodities for January 4th, 2012: Precious Metals Prices: Gold price rose on Wednesday by 0.76% to $1,612.70; Silver price on the other hand decreased by 1.61% to reach $29.10. During January, gold price inclined by 2.9%, and silver price by 4.23%.
Microsoft Corporation (NASDAQ:MSFT) Taking Comet To Court
Microsoft Corporation (NASDAQ:MSFT) has taken legal action against U.K.
retailer Comet. Microsoft Corporation (NASDAQ:MSFT) Taking Comet To Court
Microsoft Corporation (NASDAQ:MSFT) announced that it has issued proceedings
against Comet Group PLC over counterfeit Windows Vista and Windows XP recovery
CDs. The allegation is that Comet created more than 94,000 sets of counterfeit
Windows Vista and Windows XP recovery CDs in a factory in Hampshire and sold the
media to customers from its retail outlets across the U.K. David Finn, associate
general counsel, Worldwide Anti-Piracy and Anti-Counterfeiting at Microsoft
Corporation (NASDAQ:MSFT), said that, As detailed in the complaint filed today,
Comet produced and sold thousands of counterfeit Windows CDs to unsuspecting
customers in the United Kingdom. Comets actions were unfair to customers. We
expect better from retailers of Microsoft Corporation (NASDAQ:MSFT) products
and our customers deserve better, too. The alleged counterfeits were sold to
customers who had purchased Windows-loaded PCs and laptops. Microsoft Corp.
(NASDAQ:MSFT) shares were at 27.4 at the end of the last days trading. Theres
been a 5.6% change in the stock price over the past 3 months. Microsoft Corp.
(NASDAQ:MSFT) Analyst Advice Consensus Opinion: Moderate Buy Mean
recommendation: 1.95 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.77 Zacks
Rank: 79 out of 90 in the industry
retailer Comet. Microsoft Corporation (NASDAQ:MSFT) Taking Comet To Court
Microsoft Corporation (NASDAQ:MSFT) announced that it has issued proceedings
against Comet Group PLC over counterfeit Windows Vista and Windows XP recovery
CDs. The allegation is that Comet created more than 94,000 sets of counterfeit
Windows Vista and Windows XP recovery CDs in a factory in Hampshire and sold the
media to customers from its retail outlets across the U.K. David Finn, associate
general counsel, Worldwide Anti-Piracy and Anti-Counterfeiting at Microsoft
Corporation (NASDAQ:MSFT), said that, As detailed in the complaint filed today,
Comet produced and sold thousands of counterfeit Windows CDs to unsuspecting
customers in the United Kingdom. Comets actions were unfair to customers. We
expect better from retailers of Microsoft Corporation (NASDAQ:MSFT) products
and our customers deserve better, too. The alleged counterfeits were sold to
customers who had purchased Windows-loaded PCs and laptops. Microsoft Corp.
(NASDAQ:MSFT) shares were at 27.4 at the end of the last days trading. Theres
been a 5.6% change in the stock price over the past 3 months. Microsoft Corp.
(NASDAQ:MSFT) Analyst Advice Consensus Opinion: Moderate Buy Mean
recommendation: 1.95 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.77 Zacks
Rank: 79 out of 90 in the industry
Google Alert - Antiques treasure
| ||
| Collectors can cash in on gold, silver, antiques this week in Brighton Livingston Daily The guild is connected to the Treasure Hunters Roadshow, which specializes ... but antiques and collectibles are a big part of business, too," Reppuhn said. ... |
This as-it-happens Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
Gold and Crude Oil Continued to Trade Up –Recap January 4
Gold price continued to rally and rose for the second consecutive day while
silver prices changed direction and moderately declined; crude oil continued to
trade up, while natural gas spot price declined. Major currencies such as Euro
and Australian dollar changed direction and depreciated against the U.S dollar.
Here is a summary of the price developments of precious metals and energy
commodities for January 4th, 2012: Precious Metals Prices: Gold price rose on
Wednesday by 0.76% to $1,612.70; Silver price on the other hand decreased by
1.61% to reach $29.10. During January, gold price inclined by 2.9%, and silver
price by 4.23%.
silver prices changed direction and moderately declined; crude oil continued to
trade up, while natural gas spot price declined. Major currencies such as Euro
and Australian dollar changed direction and depreciated against the U.S dollar.
Here is a summary of the price developments of precious metals and energy
commodities for January 4th, 2012: Precious Metals Prices: Gold price rose on
Wednesday by 0.76% to $1,612.70; Silver price on the other hand decreased by
1.61% to reach $29.10. During January, gold price inclined by 2.9%, and silver
price by 4.23%.
Gold & Silver Prices – Daily Outlook January 5
Following the sharp gains recorded on the first business day of 2012 for both
gold and silver prices, gold price continued to rise while silver price changed
direction and moderately declined.
gold and silver prices, gold price continued to rise while silver price changed
direction and moderately declined.
2 Bullish Signals for the Nasdaq
Following Tuesday's big breakout, stocks closed mixed after some initial
profit-taking. European difficulties dominated the early trading as concerns
over the liquidity of eurozone banks and the recent hike in Spain's bond rates
reminded traders that problems there still exist. But U.S. factory orders rose
for the first time in three months, and steady buying brought prices back to
above breakout levels. At the close, the Dow Jones Industrial Average was up 21
points to 12,418, the S&P 500 rose slightly to 1,277, and the Nasdaq fell
fractionally to 2,648. The NYSE traded 758 million shares, and the Nasdaq
crossed 436 million. On the Big Board, advancers versus decliners were even, but
on the Nasdaq decliners were ahead by 1.5-to-1. Click to Enlarge In Tuesday's
Daily Market Outlook , I noted that the S&P 500 had yet to break decisively
through its 200-day moving average and that the stochastic was
"non-confirming" in that its highs were lower than prior highs. But these
concerns were satisfied by the S&P 500's clean break from its 200-day moving
average and an improving stochastic, which is now almost flat. The index still
must exceed its October high at 1,293 in order to clinch the turn up, but it is
clear that the bulls are now in charge. Click to Enlarge Although the Nasdaq has
yet to follow the positive course of the Dow indices and the S&P 500, it has
made several very positive steps in that direction. First, and most importantly,
it not only broke through its 50-day moving average, but did it with the gusto
of an opening gap, which, on Tuesday, even popped through the 200-day moving
average on an intraday thrust.
profit-taking. European difficulties dominated the early trading as concerns
over the liquidity of eurozone banks and the recent hike in Spain's bond rates
reminded traders that problems there still exist. But U.S. factory orders rose
for the first time in three months, and steady buying brought prices back to
above breakout levels. At the close, the Dow Jones Industrial Average was up 21
points to 12,418, the S&P 500 rose slightly to 1,277, and the Nasdaq fell
fractionally to 2,648. The NYSE traded 758 million shares, and the Nasdaq
crossed 436 million. On the Big Board, advancers versus decliners were even, but
on the Nasdaq decliners were ahead by 1.5-to-1. Click to Enlarge In Tuesday's
Daily Market Outlook , I noted that the S&P 500 had yet to break decisively
through its 200-day moving average and that the stochastic was
"non-confirming" in that its highs were lower than prior highs. But these
concerns were satisfied by the S&P 500's clean break from its 200-day moving
average and an improving stochastic, which is now almost flat. The index still
must exceed its October high at 1,293 in order to clinch the turn up, but it is
clear that the bulls are now in charge. Click to Enlarge Although the Nasdaq has
yet to follow the positive course of the Dow indices and the S&P 500, it has
made several very positive steps in that direction. First, and most importantly,
it not only broke through its 50-day moving average, but did it with the gusto
of an opening gap, which, on Tuesday, even popped through the 200-day moving
average on an intraday thrust.
Subscribe to:
Posts (Atom)
LinkWithin
